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The orexin system consisting of two 
hypothalamic peptides, orexin-A and 
orexin-B, and two G-protein coupled 
receptors, orexin-1 and orexin-2 re-
ceptor, has multiple important physi-
ological effects and is implicated in 
many disease states. If one wishes to 
understand these effects and to de-
velop efficient therapies for orexin-
related disorders the detailed knowl-
edge of the signalling inside the cell 
is critical. This study sheds light on 
the previously poorly characterized 
cellular signalling mechanisms used 
by the orexin-1 receptor.
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ABSTRACT 
 
The orexin-1 receptor (OX1R) is a member of a superfamily of G-protein coupled 
receptors (GPCRs). Two hypothalamic neuropeptides, orexin-A/hypocretin-1 (Ox-A) and 
orexin-B/hypocretin-2, bind to and activate OX1R and a related GPCR, the orexin-2 
receptor. The physiological effects of the orexin system include regulation of feeding, 
energy metabolism, endocrine and autonomic systems, and sleep/wake cycle. At the 
cellular level, OX1R stimulation leads to neuronal excitation, activation of the adenylyl 
cyclase pathway and several protein kinases, and an increase in the intracellular Ca2+ 
concentration ([Ca2+]i). OX1R couples to Gq/11-proteins and activates phospholipase C  
(PLC -pathway leading to release of Ca2+ from the intracellular Ca2+ stores and the 
subsequent capacitative Ca2+ entry (CCE) aiming to refill depleted stores. This is the main 
pathway utilized when high nanomolar Ox-A concentrations are evaluated, but at lower, 
and probably physiologically more relevant, concentrations there was a predominance of 
receptor-operated Ca2+ influx without any detectable release of stores. The aim of this 
study was to elucidate the poorly characterized signalling mechanisms used by the OX1R 
leading to and regulating Ca2+ responses. The investigations with the patch clamp and 
Ca2+ imaging techniques in recombinant cell models demonstrated that even a low 
nanomolar Ox-A concentration was able to evoke a highly voltage-dependent 
depolarization of the membrane, an increased ion current, and a robust elevation of 
[Ca2+]i. It was found that Ca2+ responses at low Ox-A concentrations were acutely 
dependent on voltage and extracellular Ca2+ concentration as well as being sensitive to 
blockers of receptor-operated Ca2+ entry. Protein kinase C (PKC) was found to be a crucial 
regulator of these responses. Based on the pharmacological profile of the responses and 
the experiments with dominant negative canonical transient receptor potential channel 
(TRPC) subtypes, the most probable ion channel involved in the Ca2+ influx is the 
diacylglycerol-activated and PKC-regulated TRPC3. At higher Ox-A concentrations, Ca2+ 
responses occurred also in the absence of extracellular Ca2+ and were sensitive to 
inhibitors of store release and CCE, pointing to involvement of the PLC -pathway. In 
addition to TRPC3 channel, phospholipase A2 and protein kinase D1/3 were identified as 
novel targets of OX1R mediated activation and as prominent modulators of Ca2+ 
oscillations induced by low nanomolar Ox-A concentrations. In conclusion, it was 
possible to confirm the present view of Ca2+ signalling of OX1R and to identify novel 
players in the pathways activated by the receptor. It is hoped that these results will be 
useful in constructing a more comprehensive picture of OX1R signalling and in 
developing efficient therapies for OX1R -related disorders. 
 
National Library of Medical Classification: QU 136, QU 141, QU 55.2 
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TIIVISTELMÄ 
Kaikki elävät olennot koostuvat soluista. Toimiakseen tarkoituksenmukaisesti solun on 
oltava jatkuvassa vuorovaikutuksessa ympäristönsä kanssa, mutta samalla suojattava 
itseään ympäristön mahdollisilta vaaroilta. Tämän vuoksi solua ympäröi solukalvo, joka 
läpäisee molekyylejä vain valikoidusti ja sisältää reseptoreja, jotka sitovat erilaisia 
viestiaineita ja välittävät viestejä solun sisään. Viesti etenee kemiallisina 
signalointipolkuina, kunnes solu kehittää tarkoituksenmukaisen vasteen. Oreksiini-1-
reseptori (OX1R), jonka aktivoimia signalointipolkuja tämä tutkimus tarkastelee, kuuluu 
laajaan G-proteiinivälitteisten reseptorien perheeseen yhdessä sisarreseptorinsa oreksiini-
2-reseptorin kanssa. Hypotalamuksessa tuotetut neuropeptidit oreksiini-A (Ox-A) ja 
oreksiini-B sitoutuvat solukalvolla oreksiinireseptoreihin aiheuttaen niiden aktivaation. 
Kehon oreksiinisignaloinnilla on havaittu olevan moninaisia tehtäviä mm. syömisen, 
energiametabolian, hormonien erityksen, autonomisten toimintojen ja uni/valverytmin 
säätelyssä. Solutasolla OX1R:n aktivaatio johtaa hermosolujen virittymiseen, 
adenylyylisyklaasipolun ja useiden proteiinikinaasien aktivoitumiseen sekä solunsisäisen 
kalsiumtason nousuun. Korkeilla nanomolaarisilla Ox-A-pitoisuuksilla stimuloitaessa 
OX1R aktivoi fosfolipaasi C -polun, joka johtaa solunsisäisten kalsiumvarastojen 
vapautumiseen ja sitä seuraavaan kalsiumin virtaukseen solun sisään. Sen sijaan 
matalammilla Ox-A-pitoisuuksilla reseptori näyttäisi aktivoivan solukalvon 
kalsiumkanavan ilman, että solunsisäiset kalsiumvarastot vapautuvat. Tämän 
tutkimuksen tarkoituksena oli valottaa ennestään huonosti tunnettuja kalsiumvasteisiin 
johtavia ja niitä sääteleviä OX1R:n signalointimekanismeja. Tulokset tukivat edellä 
esitettyä näkemystä OX1R:n kalsiumsignaloinnista. Proteiinikinaasi C:n havaittiin olevan 
merkittävässä roolissa Ox-A:n aiheuttamien kalsiumvasteiden säätelyssä. Tulosten 
perusteella diasyyliglyserolin aktivoima ja proteiinikinaasi C:n säätelemä TRPC3-kanava 
(canonical transient receptor potential channel 3) on todennäköisimmin vastuussa 
matalan Ox-A-pitoisuuden aiheuttamasta kalsiumvasteesta. Lisäksi fosfolipaasi A2, 
proteiinikinaasi D1 ja proteiinikinaasi D3 tunnistettiin OX1R:n aktivointikohteiksi ja 
matalan Ox-A-pitoisuuden aiheuttamien kalsiumoskillaatioiden huomattaviksi 
säätelijöiksi. Yhteenvetona tämä tutkimus valottaa aiemmin huonosti tunnettuja OX1R:n 
signalointipolkuja ja tunnistaa niiden uusia jäseniä. Tulokset ovat hyödyllisiä luotaessa 
kattavaa kuvaa OX1R:n signaloinnista ja kehitettäessä tehokkaita hoitomuotoja 
oreksiinisysteemin häiriöihin. 
 
Yleinen suomalainen asiasanasto: reseptorit; solukalvot; solut - vuorovaikutus 
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1 Introduction 
The superfamily of G-protein coupled receptors (GPCRs) is the largest group of receptors 
on the plasma membrane. They receive signals from the outside world and transmit them 
into the cell so that the cell is able to produce an appropriate response. Over 800 genes 
encode the members of this huge group of proteins (Fredriksson et al., 2003; reviewed in 
Oldham and Hamm, 2008). The importance of the GPCRs as drug targets is significant. In 
fact though the GPCR family represents the largest single fraction of the drug market, it 
has been speculated that only a very small number of the possible drugs targeting GPCRs 
have been developed so far (Fredriksson et al., 2003; Robas et al., 2003; Overington et al., 
2006; Rosenbaum et al., 2009; Millar and Newton, 2010). One member of this remarkable 
receptor family is the orexin-1 receptor (OX1R), on which this thesis is focused. 
Orexins/hypocretins, orexin-A (Ox-A) and orexin-B (Ox-B), are neuropeptides and 
hormones produced in the brain by a rather small group of neurons in the lateral 
hypothalamus (Sakurai et al., 1998; de Lecea et al., 1998). Despite the small number of 
orexin neurons (Thannickal et al., 2000; Modirrousta et al., 2005), their projections spread 
virtually throughout the whole brain, indicating that the orexins play significant roles in 
multiple brain functions (de Lecea et al., 1998; Peyron et al., 1998). In addition to the 
central nervous system (CNS), orexins are expressed and able to act locally in the 
periphery (reviewed in Kirchgessner, 2002). The orexin system participates in the 
regulation of numerous physiological functions including feeding, energy metabolism, 
digestion, endocrine secretion, autonomic regulation, reproduction, sleep/wake cycle, 
and alertness (reviewed in Carter et al., 2009). Narcolepsy/cataplexy is a disease 
characterized by excessive daytime sleepiness, episodes of muscle weakness and 
abnormalities of rapid eye movement (REM) sleep. In dogs, mutations in the gene 
encoding the orexin-2 receptor (OX2R) lead to a familial case of narcolepsy (Lin et al., 
1999) and the link between orexin system and this disease is also rather firm in humans 
(Nishino et al., 2000; Peyron et al., 2000; Thannickal et al., 2000; Dalal et al., 2001; Ripley et 
al., 2001; Higuchi et al., 2002). Furthermore, the orexin system has been implicated in 
other disease states such as sleep apnea, Parkinson’s disease, schizophrenia, depression 
and cancer (de Lecea and Sutcliffe, 2005; Spinazzi et al., 2006; Carter et al., 2009).  
At the cellular level, orexins exert their effects by binding to and activating either of 
the two distinct GPCRs, OX1R, and OX2R (Sakurai et al., 1998). Probably the most 
prominent cellular response to stimulation of OX1R is the increase in the intracellular 
calcium ion concentration ([Ca2+]i). Ca2+ is the most common second messenger within 
cells controlling all the aspects of cellular life: fertilization, proliferation, differentiation, 
development and cell death (Clapham, 1995; Berridge et al., 2000; Parkash and Asotra, 
2010). It is almost miraculous how changes in the concentration of just one element can 
lead to such a great diversity of responses. Ca2+ fluxing into the cytosol can originate from 
two separate sources: from the extracellular space through specific Ca2+ permeable 
channels or from the intracellular Ca2+ stores (Clapham, 1995; Berridge et al., 2003). In 
addition to Ca2+ entry routes, also the spatial and temporal aspects of Ca2+ elevation 
diversify the possible signals. Transient increases of [Ca2+]i lead to different responses 
than are seen with the repetitive Ca2+ signals known as Ca2+ oscillations which can carry 
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much more information in terms of amplitude, frequency, waveform or timing (Taylor 
and Thorn, 2001; Petersen et al., 2005; Parkash and Asotra, 2010).  
Ca2+ signalling of OX1R has been a topic of intense investigation. Activation of the 
phospholipase C  (PLC -pathway leading to release of Ca2+ from the intracellular stores 
by Ox-A has been firmly established by several groups (Smart et al., 1999; Kukkonen and 
Akerman, 2001; Muroya et al., 2004; Johansson et al., 2007; Ekholm et al., 2007; Johansson 
et al., 2008). Furthermore, there are many lines of evidence indicating that the primary 
response to lower concentrations of Ox-A is a Ca2+ influx from the extracellular space 
(Lund et al., 2000; Kukkonen and Akerman, 2001; Ammoun et al., 2003; Magga et al., 2006; 
Ekholm et al., 2007; Johansson et al., 2007; 2008). Although many players activated by 
OX1R stimulation and regulating the Ox-A induced Ca2+ responses have been identified, 
it is still not possible to discern the whole picture since important pieces of the puzzle are 
still missing. One special example is the still unidentified Ca2+ channels on the plasma 
membrane conducting Ca2+ into the cell after stimulation of OX1R by a low concentration 
of Ox-A. A more detailed knowledge of orexin signalling inside the cells is crucial if one 
wishes to understand the cellular and systemic impacts of orexins and to develop 
methods to restore the balance of the orexin system disturbed in many disease states.  
This study was conducted to elucidate the signalling mechanisms of OX1R at a cellular 
level. These investigations in several recombinant cell models with Ca2+ imaging and 
immunological assays as the main methods have yielded novel findings in terms of the 
protein kinases and other signalling molecules activated by Ox-A, the characteristics and 
regulation of Ox-A induced Ca2+ signals and the Ca2+ channels responsible for the Ca2+ 
influx induced by low concentrations of Ox-A. 
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2 Review of the Literature  
2.1 G-PROTEIN COUPLED RECEPTORS AND G-PROTEINS  
2.1.1 The Large and Significant Family of G-protein Coupled Receptors 
If one thinks about a single cell, it is far from an independent isolated unit but is in 
continuous contact with its environment and with other cells. The capability to sense the 
states and changes in the environment and to communicate with other cells represents a 
fundamental basis for cell survival and function. Since signalling molecules very rarely 
are able to pass through the plasma membrane protecting the cell from the possibly 
dangerous outside world, the cells have endowed their plasma membranes with specific 
receptors which can detect many different external signals and transmit their messages 
into the cells. The largest family of such membrane receptors is the family of GPCRs. It 
has been estimated that the human genome contains more than 800 genes encoding 
GPCR proteins (Fredriksson et al., 2003; reviewed in Oldham and Hamm, 2008). Thus 
about 3 - 4 % of the whole genome is dedicated to this task (Tuteja, 2009) which makes 
the GPCR superfamily not just the largest family of receptors, but also the largest of all 
protein families encoded in the genome (Lander et al., 2001; Venter et al., 2001; reviewed 
in Oldham and Hamm, 2008; Rosenbaum et al., 2009).  
The importance of GPCR family and its members as drug targets cannot be 
overestimated. It represents the largest single fraction of the drug market i.e. at least one 
third of the currently marketed pharmaceutical agents target GPCRs, accounting for 
annual sales of several billion dollars (Robas et al., 2003; Overington et al., 2006; Millar 
and Newton, 2010). Furthermore, it has been speculated that only a very small number of 
the possible drugs targeting GPCRs have been developed so far and thus the potential for 
drug discovery is enormous (Fredriksson et al., 2003; Rosenbaum et al., 2009; Millar and 
Newton, 2010). The physiological importance of GPCRs has also been underlined by 
results obtained in knockout animal models which have revealed the pathological 
phenotypes involving a wide variety of systems, such as cardiovascular, nervous, 
endocrine and sensory systems (Rohrer and Kobilka, 1998; Karasinska et al., 2003). 
Furthermore, natural mutations within the genes encoding specific GPCRs have been 
linked to several hereditary diseases (Spiegel and Weinstein, 2004). 
GPCRs have been named after their ability to couple to guanine nucleotide binding 
proteins (G-proteins), but they are also known as heptahelical receptors or 7-TM 
receptors based on their characteristic structure with 7 transmembrane (TM) domains. 
The TM regions are connected by three extracellular and three intracellular loops. The N-
terminus of the receptor is located in the extracellular space while the C-terminus is 
intracellular. The conformation of the TM domains determines the state (active/inactive) 
of the receptor. The extracellular receptor surface is critical for ligand binding and the 
intracellular receptor surface is known to be involved in G-protein recognition and 
activation (Rosenbaum et al., 2009). The GPCR family is very diverse showing only a low 
degree of sequence conservation. In addition, the length and function of the intracellular 
and extracellular portions of GPCRs differ considerably. This means that a huge variety 
of ligands (e.g. photons of light, odorants and pheromones, sweet and bitter tastes, ions, 
hormones, and neurotransmitters) can bind to the extracellular proportion of their 
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specific receptors (Oldham and Hamm, 2008; Millar and Newton, 2010) and many 
different molecules participate in signal transduction or receptor regulation (Bockaert et 
al., 2004; Tilakaratne and Sexton, 2005). The diversity of GPCR signalling is also 
underlined by the broad spectrum of biological responses evoked after the stimulation of 
these types of receptors. These include sensory perception, changes in neuronal activity, 
cell growth, and hormonal regulation (reviewed in Rens-Domiano and Hamm, 1995; 
Tuteja, 2009). 
2.1.2 Classification of G-protein Coupled Receptors 
GPCRs can be divided into five families on the basis of their sequence and structural 
similarities: 1) rhodopsin, 2) secretin, 3) adhesion, 4) glutamate, and 5) frizzled/taste2 
(Fredriksson et al., 2003; Oldham and Hamm, 2008; Rosenbaum et al., 2009). The 
rhodopsin family, which can be further subdivided into four groups: , , , and  
(Fredriksson et al., 2003), is the largest and most diverse, comprising of 672 members 
(Millar and Newton, 2010). Most of the family members share conserved sequence motifs 
such as the NsxxNPxxY motif in the seventh TM domain, the DRY motif at the border 
between the third TM domain and the second intracellular loop, the eighth -helix in the 
C-terminus and the C-terminal palmitoylation site (Fredriksson et al., 2003; Oldham and 
Hamm, 2008). The rhodopsin family is also characterized by a shorter N-terminus 
compared with all the other GPCR families (Fredriksson et al., 2003; Oldham and Hamm, 
2008). At least some of these common characteristics are believed to be important for 
protein stabilization and/or G-protein activation (Oldham and Hamm, 2008) and to result 
in shared structural features and activation mechanisms between the family members 
(Rosenbaum et al., 2009). The secretin family of GPCRs contains 15 members (Millar and 
Newton, 2010), binds rather large peptide ligands and has a long N-terminus with 
conserved cysteine residues participating in ligand binding (Fredriksson et al., 2003). 
Thirty-three members of the adhesion family have very extended N-termini, which are 
thought to be involved in cell adhesion (Fredriksson et al., 2003; Millar and Newton, 
2010). The glutamate family with 22 members (Millar and Newton, 2010) is mainly 
composed of glutamate, -aminobutyric acid (GABA), and taste receptors (Fredriksson et 
al., 2003). The shared structural feature in the family is a so-called “Venus fly trap” for 
ligand binding in the N-terminus of the receptors (Fredriksson et al., 2003). The 
frizzled/taste2 family consists of 36 members (Millar and Newton, 2010) and includes two 
distinct clusters: the frizzled receptors mediating signals from secreted glycoproteins 
termed Wnt and the TAS2 receptors participating in bitter taste perception (Fredriksson 
et al., 2003).  
2.1.3 Activation of G-proteins by G-protein Coupled Receptors  
The extracellular signals detected by GPCRs are transferred into the cells by G-proteins 
which reside on the plasma membrane adjacent to the receptor and which bind to a 
binding pocket formed by the intracellular loops and the C-terminus of GPCRs upon 
receptor activation (Oldham and Hamm, 2008; Vilardaga, 2010; Ambrosio et al., 2011). 
The G-proteins belong to a larger family of GTPases, hydrolase enzymes, that can bind 
and hydrolyse guanosine triphosphate (GTP) to guanosine diphosphate (GDP). In 
addition to large heterotrimeric G-proteins, which are the conventional coupling partners 
of GPCRs, the family of GTPases includes small GTP-binding proteins as well as many 
factors involved in protein synthesis (reviewed in Rens-Domiano and Hamm, 1995). 
Heterotrimeric G-proteins are composed of three subunits. The -subunit binds GTP and 
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possesses the intrinsic GTPase activity. The -, and -subunits form a stable complex 
which is dissociable only by denaturation (Schmidt et al., 1992). The -subunit requires 
the presence of the  subunit to allow it to fold properly (Schmidt and Neer, 1991; 
Higgins and Casey, 1994).  
Figure 1 represents the signalling cycle of heterotrimeric G-proteins, which has also 
been extensively described in several reviews (Neer, 1995; Rens-Domiano and Hamm, 
1995; Cabrera-Vera et al., 2003; Tuteja, 2009). In the inactive state, -, - and -subunits 
form a heterotrimer and the -subunit is associated with GDP. When a specific ligand 
binds to its receptor and activates it, a conformational rearrangement takes place in the 
receptor’s TM domains (particularly TM3 and TM6) which allows an interaction to occur 
between the receptor and the G-protein (Oldham and Hamm, 2008; Vilardaga, 2010; 
Ambrosio et al., 2011). Two models of interaction have been proposed. In the “collision 
model”, free lateral diffusion of molecules within the plasma membrane results in an 
interaction between the activated receptor and the G-protein. The opposing “precoupling 
model” postulates that there is an interaction between the receptor and the G-protein 
already prior to receptor activation (Oldham and Hamm, 2008; Vilardaga, 2010). Both - 
and -subunits have been shown to bind to the activated receptor (Oldham and Hamm, 
2008) and this binding lowers the affinity of -subunit for GDP. Once GDP is released, a 
stable high-affinity tetrameric complex is formed between the activated receptor and the 
heterotrimeric G-protein (Oldham and Hamm, 2008). This complex is however transient, 
since GTP, the cytosolic concentration of which is several-fold higher than that of GDP, 
rapidly binds to the - subunit (Oldham and Hamm, 2008) and destabilizes the complex. 
Both - and -subunits are released and able to activate effector systems. It is possible 
that the subunits are not completely dissociated but conformational rearrangements 
allow them to interact with downstream effectors (Vilardaga, 2010). The signalling 
through the G-protein is terminated, when GTP is hydrolysed to GDP and the -
complex binds again to the -subunit. This step is probably catalysed by a specific group 
of proteins termed regulators of G-protein signalling (RGS) (Oldham and Hamm, 2008; 
Tuteja, 2009). The ligand is released from the receptor and the cycle is ready to start all 
over again.  
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Figure 1. Receptor-mediated G-protein activation (Graphics by J. Peltonen). Binding of a 
specific ligand to its receptor induces a conformational change in the receptor structure. The 
activated receptor couples with the intracellular heterotrimeric G-protein composed of - and 
-subunits. This coupling promotes the exchange of guanosine diphosphate (GDP) for 
guanosine triphosphate (GTP) on the -subunit and the dissociation of the subunits from the 
receptor. Both - and -subunits are free to activate various effectors inside the cell. When 
the intrinsic GTPase activity of the -subunit hydrolyses GTP to GDP and Pi, the -subunit 
reassociates with the -subunit and the cycle is complete. A regulator of G-protein signalling 
(RGS) can accelerate the intrinsic GTPase activity of -subunit (Cabrera-Vera et al., 2003; 
Oldham and Hamm, 2008; Tuteja, 2009). 
2.1.4 Effectors Activated by G-proteins   
G-proteins play an important role not only in transferring the signals but also in 
determining the specificity and temporal characteristics of the cellular responses induced 
by extracellular signals (reviewed in Rens-Domiano and Hamm, 1995). Activated G-
proteins modulate the activity of various enzymes, ion channels and transcription factors, 
which are called effectors because changes in their activity lead to the changes in ionic 
composition, in second messenger levels or in transcription processes, that ultimately are 
reflected to cellular responses and in systemic functions such as embryonic development, 
gonadal development, learning and memory, and organismal homeostasis (reviewed 
Neer, 1995; Neves et al., 2002).  
There are 16 genes (Downes and Gautam, 1999) with over 20 gene products including 
the splice variants encoding for G -subunits in the mammalian genome (Oldham and 
Hamm, 2008). Based on their activation profiles and sequence similarities, -subunits can 
be divided into four families: G i/o, G s, G q/11, and G 12/13 (Oldham and Hamm, 2008). 
Each G -family activates a distinct profile of effectors. The members of G -families and 
their known effectors are listed in Table 1. Sometimes the coupling between GPCR and 
G-protein is very selective and the receptor is able to discriminate even between related 
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G-proteins within the same family. However, in many cases, a single receptor can 
activate more than one G-protein and thereby modulate multiple intracellular signalling 
pathways (Oldham and Hamm, 2008). Furthermore, a single G-protein may be capable of 
engaging multiple signalling pathways. 
 
Table 1. Classification of G -subunits and their effectors (adapted from Cabrera-Vera et al., 
2003) 
Family Member Effectors 
G i/o G i1 
G i2 
G i3 
G oA 
G oB 
G z 
G t1 
G t2 
G g 
Adenylyl cyclase 
Rap1 GTPase activating protein 
GRIN1 and 2 
GTPase of tubulin 
src 
Ca2+ and K+ channels 
cGMP-PDE 
DAG kinase 
Rho 
PI4-kinase 
G s G s(S) 
G s(L) 
G olf 
Adenylyl cyclase 
GTPase of tubulin and Src 
Adenylyl cyclase 
G q/11 G q 
G 11 
G 14 
G 15 
G 16 
Phospholipase C s and Bruton’s tyrosine kinase 
G 12/13 G 12 
G 13 
Na+/H+ exchanger 1 and phospholipase D 
p115RhoGEF and inducible nitric oxide synthase 
Abbreviations used: cGMP-PDE = cyclic guanosine monophosphate - phosphodiesterase E, 
DAG = diacylglycerol, GEF = guanine nucleotide exchange factor, GRIN = G-protein-regulated 
inducer of neurite outgrowth, GTP = guanosine triphosphate, GTPase = an enzyme 
hydrolyzing GTP, PI4 = phosphatidylinositol 4, Rap1 = Ras-related protein 1, Rho = Rho 
GTPase. 
 
Five and 12 mammalian genes (Downes and Gautam, 1999) encode for 6 G - and 12 G -
subunits, respectively (Oldham and Hamm, 2008). The association between these 
subunits is not a random process (Pronin and Gautam, 1992; Schmidt et al., 1992; Iniguez-
Lluhi et al., 1992), but different - and -subunits have varying affinities for one another 
(Yan et al., 1996). For a long time, the -complex was seen as a rather passive player in 
G-protein signalling. It was thought simply to assist the -subunit to interact with the 
receptor (Fung, 1983; Hekman et al., 1987; Florio and Sternweis, 1989) and to limit the 
signalling period by forming inactive heterotrimers with the -subunits (Neer, 1995). 
Subsequently, it was found that also the -complex can interact with and regulate a wide 
variety of second messengers in the cells (reviewed in Cabrera-Vera et al., 2003; Tuteja, 
2009) including various isozymes of the PLC  family (Blank et al., 1992; Camps et al., 
1992; Park et al., 1993; Smrcka and Sternweis, 1993), certain G-protein responsive cation 
channels (Clapham and Neer, 1997; Schneider et al., 1997; Jan and Jan, 1997), and a 
8 
 
number of kinases (Pumiglia et al., 1995; Langhans-Rajasekaran et al., 1995; Tang and 
Downes, 1997). Thus, it is evident that - and -subunits interact with a number of 
common effectors and additionally the -complex can interact with many effectors not 
regulated by -subunits. 
2.1.5 Regulation of G-protein Coupled Receptor Signalling  
The receptors do not only couple to the G-proteins, but also interact with many other 
proteins with signalling and regulatory functions (reviewed in Bockaert et al., 2004; 
Tilakaratne and Sexton, 2005; Millar and Newton, 2010). These proteins regulate all 
aspects of GPCR signalling, from the ligand binding to the receptor localization and from 
the G-protein selectivity to the receptor desensitization. The nature of the interacting 
proteins regulates the signalling specificity of a GPCR in concert with the nature of the 
heterotrimeric G proteins to which it is coupled. The availability of these proteins can 
profoundly affect the activity of the receptors. As mentioned above, one important class 
of proteins regulating GPCR signalling is the family of RGSs which act to stimulate the 
GTPase activity of G proteins (particularly of Gi/o and Gq/11) and thereby to attenuate the 
signalling process (Dohlman and Thorner, 1997; Arshavsky and Pugh, 1998; Kristiansen, 
2004) or in some cases also to speed up the activation of signalling (Zerangue and Jan, 
1998; Kristiansen, 2004).  
Typically, activation of a GPCR has five major consequences: 1) activation and 
inhibition of specific signalling pathways in the cells via G-proteins and/or G-protein-
independent signalling, 2) short-term desensitization of the receptor, 3) endocytosis of the 
receptor, 4) recycling of the receptor back to the plasma membrane, or 5) degradation of 
the receptor in lysosomes (Kristiansen, 2004). Short-term desensitization is usually 
accomplished via phosphorylation of GPCRs by G-protein coupled receptor kinases 
(GRKs) followed by -arrestin binding to the receptor. This uncouples the receptor from 
the G-protein at the plasma membrane. The complex formed by -arrestin and the 
phosphorylated receptor is then subjected to endocytosis via clathrin-coated pits. In 
endocytotic vesicle, the receptor is dephosphorylated by protein phosphatases and either 
guided back to the plasma membrane (resensitization) or shunted to lysosomes for 
degradation. Lysosomal degradation of receptors and/or the down-stream components 
leads to long-term desensitization. Other ways to down-regulate the signalling for longer 
periods of time are decreased synthesis of receptor proteins and/or downstream proteins 
and enhanced mRNA degradation.  
2.1.6 Complexity of G-protein Coupled Receptor Signalling  
The signalling of GPCRs is far more complex than originally was anticipated. Individual 
receptors may couple to more than one G-protein subtype and an individual G-protein 
can engage multiple signalling pathways. Furthermore, GPCRs are known to activate 
signalling pathways also independently of G-proteins (Rosenbaum et al. 2009; Tuteja, 
2009; Millar and Newton, 2010). It has been found that different ligands acting on the 
same receptor induce different sets of cellular responses. The ON/OFF model of receptor 
conformations cannot explain this phenomenon, but the receptors presumably display 
distinguishable active conformational states, which are induced by different agonists and 
correlate to specific signalling outputs (Rosenbaum et al., 2009; Millar and Newton, 2010; 
Vilardaga, 2010; Ambrosio et al., 2011). Dimerization/oligomerization of GPCRs further 
complicates the issue. Many GPCRs assemble with identical (homodimers) or distinct 
(heterodimer) receptors creating receptor dimers with pharmacological and functional 
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properties distinct from their monomeric units (Bai, 2004; Milligan, 2004; Oldham and 
Hamm, 2008). Given that an individual organ or a small region of a tissue may express 
up to 100 distinct GPCRs (Hakak et al., 2003), the significance of heterodimerization is 
obvious and this has been further highlighted by several studies (Lee et al., 2002; Liang et 
al., 2003). In addition to other receptors, GPCRs can also modulate the function of ion 
channels by directly interacting with them (Liu F. et al., 2000; Kitano et al., 2003). The 
diversity of GPCR signalling seems enormous and thus much work will be still needed to 
reveal individual characteristics of specific receptors as well as common themes shared 
by multiple GPCRs.  
2.2 CELLULAR CALCIUM METABOLISM  
Ionized calcium (Ca2+) is the most common second messenger in cells, ranging from 
bacteria to the specialized neurons in the human body. It controls almost everything that 
we do and impacts on nearly every aspect of cellular life: fertilization, differentiation, 
development, proliferation and ultimately cell death (Clapham, 1995; Berridge et al., 2000; 
Parkash and Asotra, 2010). Ca2+ gradients within cells have been proposed to be involved, 
even to initiate cell migration, exocytosis, lymphocyte killer cell activation, acid secretion, 
transcellular ion transport, neurotransmitter release, gap junction regulation, and 
numerous other functions (reviewed in Tsien and Tsien, 1990; Clapham, 1995). Gene 
transcription extends the impact of Ca2+ signalling into long-term changes in the life of a 
cell (reviewed in Clapham, 2007; Parkash and Asotra, 2010).  
A molecule can act as a signalling agent only if its concentration can be tightly 
regulated. Unlike other common second messengers, Ca2+ cannot be metabolized, but the 
cells have evolved numerous proteins to keep [Ca2+]i low (Clapham, 2007). Normal [Ca2+]i 
is approximately 100 nM while Ca2+ concentration in the extracellular space is 20 000-fold 
higher reaching mM range (Clapham, 2007; Parkash and Asotra, 2010). Transporter 
proteins pump Ca2+ out of the cells or into the intracellular Ca2+ stores located within cell 
organelles such as endoplasmic reticulum (ER) and mitochondria. These transporters 
include the sarcoplasmic reticulum (SR) and ER (Ca2++Mg2+)-ATPases (SERCAs), which 
transport Ca2+ into SR and ER, plasma membrane (Ca2++Mg2+)-ATPases (PMCAs) which 
pump Ca2+ out of the cells across the plasma membrane and mitochondrial Ca2+ 
transporters and channels (Berridge et al., 2000; 2003; Clapham, 2007; Parkash and Asotra, 
2010) (Figure 2). Furthermore, several buffer molecules form complexes with free Ca2+ 
thereby limiting its concentration (Berridge et al., 2000; Clapham, 2007; Parkash and 
Asotra, 2010). Ca2+ signals are conveyed through the magnitude, location and duration of 
the changes in [Ca2+]i (Barritt, 1999; Petersen et al., 2005; Parkash and Asotra, 2010). These 
are usually initiated by the binding of an extracellular signalling molecule to its plasma 
membrane receptor (Barritt, 1999; Petersen et al., 2005). Upon receptor stimulation, the 
local [Ca2+]i can rise to concentrations as high as 1 M (Berridge et al., 2000; Clapham, 
2007). Ca2+ can originate from two sources: 1) from the extracellular space through plasma 
membrane Ca2+ channels or 2) from intracellular Ca2+ stores in cell organelles (Berridge et 
al., 2003).  
Ca2+ channels on the plasma membrane (Figure 2) can be classified based on the 
mechanisms regulating their activity. Voltage-gated Ca2+ channels (VOCs) are expressed 
mostly in excitable cells but also in many nonexcitable cell types and they are activated 
by changes in membrane potential. The channels are selective to Ca2+ and modulated by 
neurotransmitters, G-proteins, and diffusible messengers (Tsien and Tsien, 1990; Berridge 
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et al., 2003; Clapham, 2007; Parkash and Asotra, 2010). There are four subtypes of VOCs: 
L-, T-, N-, and P-type. For example, activity of VOCs is responsible for example for 
contraction in muscles, pacemaking in the heart and neurotransmitter release in brain 
(Catterall, 2000). Receptor-operated Ca2+ channels (ROCs) are activated following the 
stimulation of a receptor by its specific agonist. There are two subtypes of ROCs: 1) the 
ligand-gated Ca2+ channels (for example N-methyl-D-aspartate (NMDA) receptor), which 
are directly activated by a ligand without the intervention of a diffusible cytosolic 
messenger, and 2) second messenger-operated Ca2+ channels, which are activated by a 
second messenger produced as a result of receptor activation by its ligand (Tsien and 
Tsien, 1990; Berridge et al., 2000; 2003). Second messengers proposed to activate Ca2+ 
channels include inositol 1,4,5-trisphosphate (IP3) (Kuno and Gardner, 1987; Mozhayeva 
et al., 1990; Vaca and Kunze, 1995; Kiselyov et al., 1997), diacylglycerol (DAG) (Hofmann 
et al., 1999; Okada et al., 1999), inositol 1,3,4,5-tetrakisphosphate (Irvine and Moor, 1986), 
Ca2+ itself (von Tscharner et al., 1986; Loirand et al., 1991; Braun and Schulman, 1995; 
Lidofsky et al., 1997; Congar et al., 1997; Leech and Habener, 1997), cyclic guanosine 
monophosphate (Finn et al., 1996), cyclic adenosine monophosphate (cAMP) (Finn et al., 
1996; Lenz and Kleineke, 1997), and arachidonic acid (AA) (Peppelenbosch et al., 1992; 
Shuttleworth, 1996; Munaron et al., 1997; Shuttleworth and Thompson, 1998). Some 
channels can also be directly activated by G-proteins (von zur Muhlen et al., 1991; 
Krautwurst et al., 1992; Berven et al., 1994; Iwasawa et al., 1997). In addition, store-
operated Ca2+ channels (SOCs) are sometimes classified under the superfamily of ROCs 
(Barritt, 1999), but here they will be located as a separate group in order to distinguish 
between ROCs, which are considered to be independent of the intracellular Ca2+ stores 
and SOCs, that sense the state of the stores and open when the stores are emptied (Barritt, 
1999; Putney, 2005; Clapham, 2007). The signalling pathway leading to opening of SOCs 
is described below (see chapter 2.2.1 The Phospholipase C  Pathway). It has been 
proposed that the opening of SOC does not increase the Ca2+ concentration in the cytosol 
but that Ca2+ enters directly into the empty store through the channel (Chakrabarti and 
Chakrabarti, 2006). The prolonged search for the molecular entity responsible for 
capacitative Ca2+ entry (CCE) led to the first real breakthrough, when a plasma membrane 
protein called Orai1 was identified as a channel forming subunit required for CCE (Feske 
et al., 2006; Zhang et al., 2006; Prakriya et al., 2006; Yeromin et al., 2006). The most 
probable signal mediator between the emptied intracellular Ca2+ stores and Orai1 is 
stromal interaction molecule 1 (STIM1), a single pass transmembrane protein primarily 
residing in the ER (Lewis, 2007). The exact signal transduction mechanism between these 
two proteins is currently unknown. In addition to the channel types mentioned above, 
Ca2+ can enter into the cells via mechanically operated Ca2+ channels, tonically active Ca2+ 
channels, or via gap junctions between neighbouring cells (Tsien and Tsien, 1990).  
Intracellular Ca2+ stores can be released in response to stimulation of either of two 
types of channels on ER: IP3 receptors (IP3Rs) and ryanodine receptors (Berridge et al., 
2000; 2003; Clapham, 2007; Parkash and Asotra, 2010) (Figure 2). The signalling pathway 
leading to activation of IP3Rs and discharge of Ca2+ from the intracellular stores will be 
introduced in the next chapter (2.2.1 The Phospholipase C  Pathway). Both IP3Rs and 
ryanodine receptors can be activated by Ca2+ and thus give rise to a phenomenon called 
Ca2+ induced Ca2+ release (CIRC) (Berridge et al., 2000; 2003; Parkash and Asotra, 2010).  
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Figure 2. Various ion transporters and channels participating in the regulation of Ca2+ 
homeostasis and signalling (Graphics by J. Peltonen). Mechanisms extruding Ca2+ from the 
cytosol include plasma membrane (Ca2++Mg2+)-ATPases (PMCAs) pumping Ca2+ out of the 
cell through the plasma membrane, sarcoplasmic reticulum and endoplasmic reticulum (ER) 
(Ca2++Mg2+)-ATPases (SERCAs) storing Ca2+ in ER and the mitochondrial uniporter 
transferring Ca2+ to mitochondrial stores. Additionally Na+/Ca2+ exchangers (NCX) and 
Na+/Ca2+-K+ exchangers (NCKX) on the plasma membrane exchange one Ca2+ ion for three 
Na+ ions (NCX) or co-transport one K+ ion with one Ca2+ ion in exchange for four Na+ ions 
(NCKX) lowering the intracellular Ca2+ concentration. Specific Ca2+ signals are generated 
when voltage-gated Ca2+ channels (VOCs), receptor-operated Ca2+ channels (ROCs) or store-
operated Ca2+ channels (SOCs) allow Ca2+ to flow into the cell or when Ca2+ is released from 
the ER stores via inositol 1,4,5-trisphosphate receptors (IP3Rs) or ryanodine receptors (RyRs) 
(Clapham, 2007; Parkash and Asotra, 2010). 
2.2.1 The Phospholipase C Pathway 
PLCs comprise a family of phosphodiesterase enzymes that cleave the polar head groups 
from inositol lipids (reviewed in Rebecchi and Pentyala, 2000). The enzymes within this 
family have been divided into four groups ( , , , and ) based on their structural 
differences. The PLC -subfamily consists of 4 isozymes ( 1 - 4) and additional splice 
variants (reviewed in Rhee, 2001) and is characterized by an extended C-terminal 
sequence (reviewed in Exton, 1996; Morris and Scarlata, 1997). Of these isozymes, PLC 1 
and PLC 3 are the most widely expressed in mammalian tissues (reviewed in Rebecchi 
and Pentyala, 2000; Rhee, 2001). The main function of PLCs is to hydrolyze the highly 
phosphorylated lipid, phosphatidylinositol 4,5-bisphosphate (PIP2), and to generate the 
ubiquitous second messengers IP3 and DAG in response to plasma membrane receptor 
stimulation (reviewed in Rebecchi and Pentyala, 2000). The PLC  isozymes of PLC family 
are activated by the stimulation of receptors coupled to Gq/11- (Smrcka et al., 1991; Taylor 
et al., 1991; Lee et al., 1992; Wu et al., 1992; reviewed in Exton, 1996; Yoshida and Imai, 
1997; Rebecchi and Pentyala, 2000) or Gi/o-subtypes (Moriarty et al., 1990; reviewed in 
Yoshida and Imai, 1997) of G-proteins. Both - and -subunits of G-proteins have been 
shown to activate PLC  (Lee et al., 1992; Wu et al., 1992; Blank et al., 1992; Camps et al., 
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1992; Park et al., 1993; Smrcka and Sternweis, 1993; reviewed in Morris and Scarlata, 1997; 
Yoshida and Imai, 1997; Rebecchi and Pentyala, 2000) by interacting with separate 
regions of the enzyme (reviewed in Yoshida and Imai, 1997; Rhee, 2001). Since activation 
via the -subunit seems to be weaker, it has been suggested that only abundant G-
protein heterotrimers of Go/i-family can produce sufficient amounts of activated -
subunits for PLC  activation (Exton, 1996; Morris and Scarlata, 1997). Other PLC 
subfamilies ( , , and ) do not seem to be regulated by G-proteins (Lopez et al., 2001, 
reviewed in Rhee and Choi, 1992, Morris and Scarlata, 1997). The activity of PLC  is also 
regulated by phosphorylation induced by cAMP-dependent protein kinase (PKA) and/or 
by protein kinase C (PKC) (Rebecchi and Pentyala, 2000) and the activity of all isozymes 
in PLC superfamily is dependent on Ca2+ (reviewed in Exton, 1996; Rhee, 2001). One 
interesting feature of PLC s is that they function as GTPase activating proteins for their 
G q/11 activator thereby providing a feedback mechanism to limit their own activity 
(Biddlecome et al., 1996; reviewed in Morris and Scarlata, 1997; Rhee, 2001).  
IP3 released by action of PLC  (or other PLC) is a soluble molecule, which can diffuse 
from the plasma membrane to the cytosol. There it binds to IP3R in the ER. Three 
isoforms of IP3Rs derived from different genes have been identified to date (reviewed in 
Yoshida and Imai, 1997; Foskett et al., 2007) and they are expressed in a tissue- and cell 
type-specific manner while type 1 IP3R is the most prevalent (Nakagawa et al., 1991; 
Sudhof et al., 1991; Ross et al., 1992; De Smedt et al., 1994). IP3Rs belong to a superfamily 
of ion channels with six TM domains but they are unique in their localization near to 
intracellular Ca2+ stores in the ER. Four monomeric subunits of IP3Rs come together to 
form a massive homotetrameric nonselective cation channel (Taylor and Laude, 2002; 
Clapham, 2007; Parkash and Asotra, 2010).  
The activity of IP3Rs is biphasically regulated by Ca2+ (Taylor and Laude, 2002; Parkash 
and Asotra, 2010). Low levels of Ca2+ are stimulatory while higher concentrations become 
inhibitory (Parker and Ivorra, 1990; Bezprozvanny et al., 1991; Parys et al., 1992; reviewed 
by Berridge et al., 2000; Clapham, 2007). This might represent an important feedback 
mechanism to protect the cell from the toxic effect of high [Ca2+]i. It seems likely that Ca2+ 
binds to two distinct sites on the channel complex and the role of IP3 is to promote 
channel opening by controlling whether Ca2+ binds to the stimulatory or inhibitory sites. 
Working in conjunction, IP3 and Ca2+ activate the IP3R complex and allow release of Ca2+ 
from the intracellular Ca2+ stores (Taylor and Laude, 2002). The release triggers Ca2+ influx 
from the extracellular space through SOCs in order to refill the emptied stores (Clapham, 
2007). The conventional view of PLC -pathway starting from the activated receptor and 
leading to the Ca2+ influx from the extracellular space is depicted in Figure 3. 
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Figure 3. Conventional view of the phospholipase C (PLC )-pathway (Graphics by J. 
Peltonen). Binding of a specific ligand to its receptor induces activation of the heterotrimeric 
Gq-protein and dissociation of the - and -subunits. -subunit activates PLC  on the plasma 
membrane. PLC hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP2) and generates 
diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). IP3 diffuses to the cytosol and 
binds to IP3Rs on the endoplasmic reticulum (ER). This leads to the discharge of the Ca
2+ 
stores on the ER. Release of Ca2+ from the intracellular sources induces capacitative Ca2+ 
entry (CCE) from the extracellular space which aims to refill the emptied stores.  
 
Several protein kinases including PKA, PKC and Ca2+/calmodulin-dependent protein 
kinase (CAMKII) have been shown to regulate the activity of IP3Rs via phosphorylation 
(Supattapone et al., 1988; Volpe and Alderson-Lang, 1990; Ferris et al., 1991; Quinton and 
Dean, 1992; Joseph and Ryan, 1993). The signalling of IP3 is terminated when IP3 is further 
converted by the action of several distinct kinases and phosphatases to a variety of 
inositol phosphates, some of which have also been implicated in intracellular signalling 
(reviewed in Rhee, 2001).  
Release of stored Ca2+ and Ca2+ influx through SOCs are not the only signalling events 
following the activation of PLC , but DAG produced along with IP3 also plays important 
signalling roles while staying bound to the plasma membrane. DAGs are glycerol 
derivatives in which two hydroxyl groups are substituted by fatty acids through ester 
bond formation (Brose and Rosenmund, 2002). The mammalian cell contains at least 50 
structurally distinct species of the physiological relevant isomer of DAG, 1,2-diacyl-sn-
glycerol, whose fatty acyl groups can be polyunsaturated, di-unsaturated, mono-
unsaturated, or saturated (Hodgkin et al., 1998; Wakelam, 1998). Polyunsaturated forms 
of DAG produced by hydrolysis of PIP2 by PLCs seem to be the most effective moieties in 
signalling (Hodgkin et al., 1998; Wakelam, 1998). DAGs can also be produced by other 
means, especially via the action of phospholipase D (PLD) on phosphatidylcholine to 
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form phosphatidic acid (PA), which is in turn converted to DAG in a reaction catalyzed 
by phosphatidic acid phosphatase. Usually the same receptors activating PLCs also 
activate PLD. However, DAG species produced via the PLD pathway are mono-
unsaturated or saturated and they are unlikely to play a role in cellular signalling 
(Hodgkin et al., 1998; Wakelam, 1998). 
The main target of DAG is PKC. The large PKC family of serine/threonine kinases 
comprises 10 members which can be classified based on their divergent N-terminal 
regulatory domains. Conventional PKC isoforms ( , I, II, and ) contain binding 
domains for DAG, Ca2+ and lipids (phosphatidyl-serine, PIP2). Novel PKCs ( , , , and 
/L) are activated by DAG and bind lipids but unlike conventional isoforms, these 
enzymes are insensitive to Ca2+. Atypical PKC enzymes (ζ, ι/ ) are not regulated by either 
DAG or by Ca2+ while still possessing binding domain for lipids (Newton, 2001; van 
Rossum and Patterson, 2009). DAG binds to the cysteine rich region (C1 domain) of 
conventional and novel PKC isoforms (Muramatsu et al., 1989; Kaibuchi et al., 1989; 
Burns and Bell, 1991) leading to the activation and translocation of these enzymes to the 
plasma membrane (reviewed in Bell and Burns, 1991; Hug and Sarre, 1993). After 
activation, PKCs are thought to regulate a multitude of intracellular processes, ranging 
from cell proliferation to apoptosis and from regulation of transcription to 
neurotransmitter/hormone release (reviewed in Nishizuka, 1995; Dempsey et al., 2000). 
Regulation of cell proliferation and apoptosis by PKC can be mediated via its effects on 
protein kinases of the mitogen activated protein kinase/extracellular signal regulated 
kinase (MAPK/ERK) pathway (reviewed in Rozengurt, 2007).  
In addition to the PKC isoforms, DAG is able to bind to the C1 domains of a large 
number of proteins with diverse functions. The known C1-domain-containing proteins 
activated by DAG are chimaerins (Ahmed et al., 1990; 1993; Areces et al., 1994; Caloca et 
al., 1997; 2001), protein kinase Ds (PKDs) (Valverde et al., 1994; Hayashi et al., 1999; 
Sturany et al., 2001), Ras guanine nucleotide releasing protein (Ebinu et al., 1998; Lorenzo 
et al., 2000), Munc13s (Betz et al., 1998) and DAG kinases (Shindo et al., 2001; Shindo et al., 
2003; reviewed in Brose and Rosenmund, 2002). The family of PKDs consists of 
PKC /PKD1 (Johannes et al., 1994; Valverde et al., 1994), PKD2 (Sturany et al., 2001) and 
PKC /PKD3 (Hayashi et al., 1999). PKDs are serine/threonine kinases with distinct 
characteristics from the PKC kinase family (Valverde et al., 1994; Van Lint et al., 1995). 
They are independent of Ca2+ (Van Lint et al., 1995) but their activation usually requires 
phosphorylation of specific residues by novel PKC isoforms (Zugaza et al., 1996; 1997; 
Matthews et al., 1997; Waldron et al., 1999; 2001). PKDs have been shown to play 
essential roles in many cellular functions, including Golgi organization and function, 
immune response, proliferation and apoptosis (reviewed in Rykx et al., 2003). The 
termination of signalling of polyunsaturated DAG molecules occurs via actions of DAG 
kinases and DAG lipases which convert DAG into PA and AA, respectively (reviewed in 
Wakelam, 1998; Hodgkin et al., 1998).  
2.2.2 Calcium Oscillations 
As described earlier, Ca2+ is a ubiquitous signalling agent, necessary for life. However, a 
prolonged increase in [Ca2+]i can be deleterious and lead to cell death. Therefore, Ca2+ 
signals are usually delivered as brief transients instead of as a sustained elevation of 
[Ca2+]i (Berridge et al., 2000; Clapham, 2007; Parkash and Asotra, 2010). Single peaks in 
[Ca2+]i can activate certain cellular processes, such as secretion of cellular material in 
membrane-bound vesicles, or they can trigger muscle contraction (Berridge et al., 2000). 
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However, more information can be encoded into repetitive transients known as Ca2+ 
oscillations in terms of amplitude, frequency, waveform or timing (Berridge et al., 2000; 
Taylor and Thorn, 2001; Parkash and Asotra, 2010). For example, the pattern and 
frequency of Ca2+ oscillations encodes for differential regulation of cellular functions, 
including gene expression (Dolmetsch et al., 1998; Li et al., 1998) and cell metabolism 
(Kasai and Augustine, 1990; Tse et al., 1993; Pralong et al., 1994; Hajnoczky et al., 1995) 
while the cell can also intepret modest changes in the amplitude of Ca2+ spikes, for 
example by activating different genes in response to the changes in the amplitudes 
(Dolmetsch et al., 1997). The widely accepted current view is that Ca2+ oscillations are a 
nearly universal phenomenon occurring under physiological conditions in response to a 
wide range of signals in both excitable and non-excitable cells (Tsien and Tsien, 1990; 
Berridge, 1995). Several studies have demonstrated Ca2+ oscillations in response to 
stimulation of GPCRs with physiological concentrations of agonists (which are often 
lower than the concentrations generally used in signalling studies, i.e. concentrations 
known to elicit a sustained elevation in [Ca2+]i) (Fu et al., 1991; Akagi et al., 1997; Sergeeva 
et al., 2000; Luo et al., 2001; Wu X. et al., 2002; Rey et al., 2006b).  
In electrically excitable cells, the oscillations are generated by VOCs driven by 
membrane potential fluctuations (reviewed in Tsien and Tsien, 1990). Most models of 
Ca2+ oscillations induced by GPCR stimulation in non-excitable cells predict the 
involvement of periodic release and the reuptake of Ca2+ from the intracellular Ca2+ stores. 
Additionally, Ca2+ influx from the extracellular space has an essential role in refilling the 
stores and maintaining the oscillation pattern (reviewed in Tsien and Tsien, 1990; Taylor 
and Thorn, 2001; Berridge, 2005). Sometimes, both initial Ca2+ release from IP3-sensitive 
stores and subsequent CIRC from ryanodine-sensitive stores are believed to be involved 
(reviewed in Tsien and Tsien, 1990; Mikoshiba et al., 1993; Bootman et al., 1996). However, 
there is growing body of evidence indicating that also in non-excitable cells, the 
oscillations can be derived solely from the function of the plasma membrane Ca2+ 
channels independently of Ca2+ stores (Fu et al., 1991; Grimaldi et al., 2003; Shlykov and 
Sanborn, 2004; Rey et al., 2006b). Despite these seemingly contradictory results and 
models, one can draw the conclusion that Ca2+ influx plays a major role in generation and 
maintenance of oscillatory Ca2+ signals. 
There is no consensus concerning the Ca2+ influx pathway involved in Ca2+ oscillations 
but at least CCE via SOCs (Bootman et al., 1996; Sergeeva et al., 2000; Bird and Putney, 
2005) and a novel non-capacitative Ca2+ entry activated by AA (Akagi et al., 1997; 
Shuttleworth and Thompson, 1999; Wu X. et al., 2002) have been proposed as candidates. 
Neither of these Ca2+ entry pathways has been suggested to be entirely responsible for the 
Ca2+ oscillations but to function in cooperation with the intracellular Ca2+ stores. The 
studies implicating the exclusive contribution of Ca2+ entry in oscillatory Ca2+ signals 
mostly identify canonical transient receptor potential channels (TRPC) as the channels 
responsible for the Ca2+ entry and oscillations (Grimaldi et al., 2003; Shlykov and Sanborn, 
2004; Rey et al., 2006b). This large family of cation channels are more closely described in 
the next chapter (2.2.3 Canonical Transient Receptor Potential Channels). Now an attempt 
will be made to clarify the possible role of AA in triggering the Ca2+ influx involved in 
Ca2+ oscillations. 
AA can be produced via multiple pathways in the cells. It is present in the 
phospholipids of plasma membranes of the cells and can potentially be released by a 
number of phospholipases (reviewed in Dennis et al., 1991). Activation of PLC or PLD 
generates AA indirectly via DAG, which can be converted to AA by diglyceride lipase. 
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On the other hand, phospholipase A2 (PLA2) generates AA as a direct product after 
phospholipid hydrolysis (reviewed in Diaz and Arm, 2003; Hirabayashi et al., 2004). PLA2 
can be activated by various extracellular stimuli including agonists of GPCRs. Thus 
GPCRs seem to trigger multiple either independent or interconnected pathways (see for 
example Lin et al., 1992; Winitz et al., 1994; Xing and Insel, 1996; Handlogten et al., 2001; 
Kurrasch-Orbaugh et al., 2003 or review Rozengurt, 2007). AA has been shown to induce 
Ca2+ influx in various cell types (Shuttleworth, 1996; Munaron et al., 1997; Shuttleworth 
and Thompson, 1998) and several reports have demonstrated its significant role in Ca2+ 
oscillations (Shuttleworth, 1996; Akagi et al., 1997; Shuttleworth and Thompson, 1998; 
1999; Wu X. et al., 2002). Shuttleworth et al. (2004) proposed a model of Ca2+ oscillations 
in which stimulation of GPCR with a low concentration of agonist leads to a generation of 
AA and activation of a novel non-capacitative Ca2+ influx pathway, called AA-regulated 
Ca2+ entry (ARC). Ca2+ flowing to the cytosol increases the likelihood that already a low 
concentration of IP3 will trigger repetitive Ca2+ release. Thus Ca2+ influx through ARC is 
essential for the generation of Ca2+ oscillations and in the modulation of the frequency 
although Ca2+ is originated from the intracellular IP3-sensitive Ca2+ stores. At higher 
concentrations of agonist, the amount of generated IP3 is sufficient to discharge the stores 
alone and to activate CCE which inhibits ARC. This leads to a sustained Ca2+ elevation 
instead of oscillations. Furthermore, they argued that the channels responsible for ARC 
and TRP channels are different molecular entities. However, involvement of TRP 
channels in Ca2+ oscillations have been demonstrated in several studies (Wu X. et al., 2002; 
Grimaldi et al., 2003; Launay et al., 2004; Shlykov and Sanborn, 2004; Bird and Putney, 
2005; Rey et al., 2006b; Wedel et al., 2007) and therefore multiple Ca2+ entry pathways 
may well be involved in Ca2+ oscillations depending on the specific GPCR and cell model.  
2.2.3 Canonical Transient Receptor Potential Channels 
TRP ion channels were first identified in Drosophila visual system. It was found that a 
spontaneously occurring Drosophila mutant lacking a functional copy of the trp gene 
responded to continuous light with a transient receptor potential instead of a sustained 
response (reviewed in Minke and Cook, 2002; Flockerzi, 2007). The channel encoded by 
the gene was named after the abnormal response as the TRP channel. To date, at least 28 
mammalian homologs of this channel encoded by distinct genes have been identified 
(Clapham et al., 2003; Flockerzi, 2007; Rowell et al., 2010). All the members have similar 
overall structure with six TM domains, both N- and C-terminus in the cytosol and a pore-
forming region between the fifth and the sixth TM domain (Benham et al., 2002; 
Chakrabarti and Chakrabarti, 2006; Rowell et al., 2010) (Figure 4). The members of TRP 
superfamily show a high degree of structural diversity and the most conserved region is 
the one forming the pore, which shares structural homology with the Drosophila TRP 
(Minke and Cook, 2002; Rowell et al., 2010). A functional channel is formed when four 
similar or different TRP subunits assemble together to form homo- or heterotetramer 
(Benham et al., 2002; Clapham, 2003, Chakrabarti and Chakrabarti, 2006; Flockerzi, 2007). 
Often the channels are reported to be nonselective and permeable to Ca2+, other divalent 
cations and Na+ (reviewed in Clapham, 2003; Vazquez et al., 2004; Pedersen et al., 2005; 
Chakrabarti and Chakrabarti, 2006; Parkash and Asotra, 2010; Rowell et al., 2010). TRP 
channels have a central role in Ca2+ homeostasis in virtually all cells (Benham et al., 2002). 
Many members of the superfamily are utilized in mediating sensory signals, such as light, 
smells, pheromones, bitter or sweet tastes and changes in temperature (Clapham, 2003; 
Flockerzi, 2007).  
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Figure 4. Architecture of transient receptor potential (TRP) channels (adapted from Clapham 
et al. 2001). TRP channels contain six transmembrane (TM) domain (S1 – S6). Both N- and 
C-terminus are in the intracellular site of the membrane. Channels are nonselective and 
permeable to both calcium ions (Ca2+) (and other divalent cations) and sodium ions (Na+). 
 
The superfamily of mammalian TRP channels can be divided into six sub-families (Minke 
and Cook, 2002; Clapham, 2003; Flockerzi, 2007). The canonical TRP (TRPC) channel 
subfamily is one of them and consists of 7 members, TRPC1-7 (Benham et al., 2002; 
Clapham, 2003; Clapham et al., 2003; Flockerzi, 2007). This subfamily is further divided 
into three groups based on sequence homology and functional similarities (Clapham, 
2003). The first group includes TRPC1, TRPC4 and TRPC5. The first identified human 
homolog of Drosophila TRP channel was TRPC1 channel (Wes et al., 1995; Zhu et al., 1995; 
Zitt et al., 1996). It has a widespread expression and ability to coassemble with all of the 
other TRPCs (Xu et al., 1997; Lintschinger et al., 2000; Strubing et al., 2001). Recombinant 
expression of TRPC1 and either TRPC4 or TRPC5 in cells results in a novel nonselective 
heterotetrameric channel with distinct properties from homotetrameric channels 
(Strubing et al., 2001). Murine TRPC4 and TRPC5 can form homotetrameric cation 
channels (Okada et al., 1998; Schaefer et al., 2000). TRPC2 alone forms the second group 
of TRPC channels. It is expressed in tissues of mouse, rat and bovine, but it is a 
pseudogene in humans (Wes et al., 1995; Wissenbach et al., 1998; Liman et al., 1999; 
Vannier et al., 1999; Hofmann et al., 2000). TRPC2 has been postulated to play a role in 
pheromone signalling (Liman et al., 1999; Stowers et al., 2002; Leypold et al., 2002). The 
third group of TRPC channels encompasses TRPC3, TRPC6 and TRPC7 channels, which 
are characterized by their low selectivity for Ca2+ over Na+ and their sensitivity to [Ca2+]i 
(Zitt et al., 1997; Boulay et al., 1997; Okada et al., 1999; Jung et al., 2002; Estacion et al., 
2006 reviewed in Dietrich et al., 2005; Eder et al., 2005). TRPC3 has been reported to be 
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constitutively active (Hurst et al., 1998; Albert et al., 2006). Most mammalian cells express 
more than one type of TRPC channels (reviewed in Chakrabarti and Chakrabarti, 2006). 
The activation mechanisms of TRPC channels have been under an intense 
investigation. They have been acknowledged to be good candidates for both SOCs and 
ROCs activated by stimulation of GPCRs and receptor tyrosine kinases which activate the 
PLC signalling pathway (Clapham, 2003; 2007; Parkash and Asotra, 2010; Rowell et al., 
2010). There is abundant evidence both for and against these functions. The first view is 
supported by the findings that TRPC channels are often activated after Ca2+ release from 
the intracellular Ca2+ stores and that there seems to be a physical contact between the 
channels and IP3Rs. TRPC1/4/5 are generally thought to be the primary channels 
mediating CCE (Chakrabarti and Chakrabarti, 2006; Ambudkar et al., 2007). The physical 
interaction between IP3R and TRPCs has been directly demonstrated in the cases of 
TRPC1 (Lockwich et al., 2000; Singh et al., 2000; Mehta et al., 2003) and TRPC3 (Kiselyov 
et al., 1998; Boulay et al., 1999; Ma et al., 2000; Zhang et al., 2001). All members of TRPC 
family possess a similar binding site for IP3R in their C-terminus and are therefore 
capable of functioning as units of SOCs. A ubiquitous Ca2+ binding protein, calmodulin, 
competitively binds to the same region of the TRPC sequence as IP3R and inhibits the 
channel activity (Tang et al., 2001; Zhang et al., 2001). The function of TRPC channels can 
therefore be indirectly modulated by [Ca2+]i. In addition to TRPC1 (Zitt et al., 1996; Zhu et 
al., 1996; Sinkins et al., 1998; Liu X. et al., 2000; Xu and Beech, 2001; Brough et al., 2001) 
and TRPC3 (Groschner et al., 1998; Li et al., 1999), also TRPC2 (Vannier et al., 1999; Gailly 
and Colson-Van Schoor, 2001; Jungnickel et al., 2001), TRPC4 (Philipp et al., 2000; Freichel 
et al., 2001), TRPC5 (Kanki et al., 2001), and TRPC7 (Riccio et al., 2002) seem to be 
activated after store depletion. TRPC channels have been shown to associate with STIM1 
and Orai1 proteins, recently characterized essential components for CCE (Ambudkar et 
al., 2007; Liao et al., 2009; Rowell et al., 2010). However, nearly every report showing a 
store-operated activation of a specific TRPC channel seems to be accompanied by another 
study pointing to another direction. PLC  and other components of the 
phosphatidylinositol pathway are important in the activation of Drosophila TRP channels 
(Harteneck et al., 2000; Clapham et al., 2001; Montell et al., 2002; Hardie, 2003). In 
accordance with this hypothesis, many TRPC channels have been demonstrated to be 
activated by the downstream products of PLC hydrolysis, most notably by DAG but also 
by AA or some other metabolite (reviewed in Benham et al., 2002; Montell et al., 2002). 
DAG potentiation of TRPC function seems to be a direct effect and not mediated via 
activation of PKC by DAG (Zitt et al., 1997). The principal targets for DAG activation 
seem to be TRPC3/6/7 (Hofmann et al., 1999; Ma et al., 2000; Venkatachalam et al., 2001; 
Chakrabarti and Chakrabarti, 2006; Rowell et al., 2010). Although often described as a 
SOC, TRPC1 can also function as a DAG activated channel in a recombinant model 
system in the presence of low extracellular Ca2+ (Lintschinger et al., 2000; reviewed in 
Pedersen et al., 2005). There is recent evidence to suggest that STIM1 and Orai1 proteins 
are not needed for TRPC1 function (DeHaven et al., 2009; Rowell et al., 2010) and that the 
complexes formed by TRPC channels and Orai1 proteins can also behave as ROCs (Liao 
et al., 2009). TRPC4 and TRPC5 are not activated by DAG, but probably by some other 
product downstream of PLC activation (Philipp et al., 1998; Okada et al., 1998; Hofmann 
et al., 1999; Schaefer et al., 2000). One candidate is AA (Broad et al., 1999; Mignen and 
Shuttleworth, 2000), which has been shown to activate Drosophila TRP-like (TRPL) 
channels (Chyb et al., 1999). One potential mediator between GPCR and TRPC is also 
PIP2 (reviewed in Clapham, 2003). Taking these various results and models into 
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consideration, it can be concluded that TRPC channels likely participate in the formation 
of several different types of ion channels (Chakrabarti and Chakrabarti, 2006). Flockerzi 
(2007) concluded that most TRP channels do not fulfil the characteristics typical of SOCs 
but it still may turn out that one or more of TRP channels participate in CCE. 
The important role of TRPC channels in the generation of Ca2+ oscillations in non-
excitable cells has already been mentioned above. DAG analogs have been shown to 
promote Ca2+ oscillation in some cell models and the effect has been postulated to be 
mediated via DAG-activated TRPC3 (or TRPC6/7) (Grimaldi et al., 2003; Shlykov and 
Sanborn, 2004). In the model system used by Bird and Putney (2005), recombinantly 
expressed TRPC3 was able to support the Ca2+ oscillation induced by metacholine (an 
agonist of one GPCR, the cholinergic muscarinic receptor) when SOCs were inhibited. 
Similarly, Wedel et al. (2007) observed that Ca2+ oscillations induced by metacholine 
could be supported by non-store-operated channel mechanisms. They observed Ca2+ 
entry in response to AA in human embryonic kidney cells (HEK293) and Ca2+ oscillations 
in TRPC3-expressing cells even when SOCs were blocked. There is also evidence that 
TRPC4 or TRPC1 may be involved in Ca2+ oscillations elicited by stimulation of GPCRs 
(Wu X. et al., 2002; Rey et al., 2006b). The study of Wu X. et al. (2002) linked Ca2+ 
oscillations induced by carbachol (an agonist of the muscarinic receptor) together with 
AA and TRPC4. They characterized Ca2+ oscillations that are independent of intracellular 
Ca2+ stores, but maintained by AA regulated Ca2+ entry, probably through TRPC4. Rey et 
al. (2006b) characterized Ca2+ oscillations induced by stimulation of the Ca2+ sensing 
receptor by aromatic amino acids in HEK293 cells and reported independence of PLC -
pathway and crucial role of TRPC1. They proposed a model where the receptor forms a 
multiprotein complex through its cytoplasmic tail with GTPase Rho, filamin-A (a 
potential scaffolding protein) and TRPC1. This interaction leads to TRPC1 channel 
opening and Ca2+ entry. Calmodulin which is activated by the increase in [Ca2+]i 
participates in the generation of oscillations by inhibiting TRPC1 channel and initiating 
the downward phase of the Ca2+ spike. 
The multiprotein signalling complexes seem to be common among GPCRs and 
especially signalling molecules of PLC -pathway have been shown to form assemblies. 
One example comes from the visual system of Drosophila where a scaffolding protein, G-
protein, PLC, TRP and TRPL channels, PKC and calmodulin exist as a united complex 
(reviewed in Barritt, 1999; Bockaert et al., 2004). Scaffolding proteins are generally 
required to bring the participants together and the complexes are located in specific 
regions at the plasma membrane, such as caveolaes. Co-immunoprecipitation studies 
have revealed multiple interaction partners of mammalian TRPC channels in addition to 
IP3R mentioned already earlier. TRPC1 seems to form a multiprotein complex with 
SERCA, G q/11 and PLC  (Lockwich et al., 2000). It can directly interact with one GPCR, 
the metabotropic glutamate receptor mGluR1 (Kim et al., 2003) and co-
immunoprecipitates with an scaffolding protein, ezrin and an abundant protein in 
caveolaes, caveolin-1 (Lockwich et al., 2000; Singh et al., 2000; Brazer et al., 2003). TRPC4 
forms a multiprotein complex with PLC, the scaffolding protein Na+/H+ exchanger 
regulatory factor and the actin cytoskeleton (Tang et al., 2000) and the complex is located 
in caveolae (Torihashi et al., 2002). 
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2.3 THE OREXIN SYSTEM  
2.3.1 Discovery of Orexin System  
The orexin system consisting of two hypothalamic neuropeptides orexin-A/hypocretin-1 
(Ox-A) and orexin-B/hypocretin-2 (Ox-B) and the corresponding GPCRs orexin-1 receptor 
(OX1R) and orexin-2 receptor (OX2R) was found by two independent research groups in 
1998 using two different approaches (de Lecea et al., 1998; Sakurai et al., 1998). First de 
Lecea et al. (1998) as a result of their search for unique mRNA transcripts in the 
hypothalamus described two hypothalamic peptides, hypocretin-1 and -2 (hypothalamic 
member of the incretin family), derived from the same precursor (preprohypocretin) and 
sharing substantial amino acid identities with each other and with the gut hormone, 
secretin. Only few weeks later a report with a careful characterization of two 
hypothalamic peptides named as orexin-A and orexin-B based on their orexinergic effects 
when administered centrally to rats was published by Sakurai et al. (1998). The aim of the 
study of Sakurai et al. was to screen extracts from rat and bovine brains for possible 
ligands of orphan GPCRs. Consequently, in the same report they were able to describe 
OX1R (orphan receptor HFGAN72) and OX2R as specific receptors for orexin peptides. 
Soon it became clear that hypocretins and orexins were two different names for the same 
peptides. No consensus on the nomenclature has been reached and both are still in use 
today, but here the name orexin is used consistently for clarity’s sake.    
2.3.2 General Aspects of Orexins and Their Receptors   
Ox-A and Ox-B are derived from the same 131-amino acid precursor peptide prepro-
orexin (PPO) by proteolytic processing (de Lecea et al., 1998; Sakurai et al., 1998). In the 
human genome, the gene encoding PPO is located in chromosome 17q21 and consists of 
two exons and one intron (de Lecea et al., 1998; Sakurai et al., 1998; 1999). Ox-A is a 33-
amino acid peptide of 3562 Da with two sets of intrachain disulfide bonds formed by four 
cysteine residues (Sakurai et al., 1998). Ox-B is a linear 28-amino acid peptide of 2937 Da 
consisting of two -helices (Lee et al., 1999). The sequences of orexin peptides are 46 % 
identical with each other (Sakurai et al., 1998) (Figure 5). Both peptides are C-terminally 
amidated and the N-terminus of Ox-A is additionally protected by pyroglutamyl residue 
(Sakurai et al., 1998; Lee et al., 1999). The functional significance of the structural 
differences of the peptides can be the higher stability of Ox-A (Kastin and Akerstrom, 
1999). Since both termini of Ox-A are blocked by posttranslational modifications and it 
has two intrachain disulfide bonds, this peptide may be more resistant to inactivating 
peptidases. Sakurai et al. (1998) found no significant structural similarities to known 
families of regulatory peptides while de Lecea et al. (1998) reported a substantial identity 
with secretin. Both peptides, Ox-A and Ox-B, are highly conserved among the species 
from the frog, Xenopus laevis (Shibahara et al., 1999) to mammals (Sakurai et al., 1998; 
Dyer et al., 1999). 
 21 
 
 
Figure 5. Amino acid sequence of human orexin-A (Ox-A) and orexin-B (Ox-B) (adapted from 
Spinazzi et al., 2006). Both peptides are C-terminally amidated. Additionally Ox-A possesses 
an N-terminal pyroglutamyl residue and two intramolecular disulfide bridges between cysteine 
residues. Identical amino acids between the two peptides are shaded.  
 
De Lecea et al. (1998) did not identify receptors for the novel peptides but proposed that 
they acted through dedicated GPCRs that activate adenylyl cyclase (AC). They also 
predicted the existence of two receptor subtypes based on the differences in amino acid 
sequences of the two orexin peptides. OX1R and OX2R were identified by Sakurai et al. 
(1998). The receptors greatly resemble each other, sharing an amino acid identity of 64 % 
(Sakurai et al., 1998). They have a classical structure of GPCRs with seven TM domains, 
an extracellular N-terminus and a cytosolic C-terminus (Figure 6). They belong to the 
group of the rhodopsin family of GPCRs (Fredriksson et al., 2003). OX1R comprises 425 
amino acids and OX2R 444 amino acids (reviewed in Kukkonen et al., 2002). Both receptor 
genes are highly conserved between the species (Sakurai et al., 1998; reviewed in 
Kukkonen et al., 2002). OX1R have been reported to exclusively couple to the Gq/11 
subgroup of G-proteins while OX2R interacts also with Gi/o and Gs (Sakurai et al., 1998; 
van den Pol et al., 1998; Karteris et al., 2001; Randeva et al., 2001; Zhu et al., 2003). As a 
result, OX1R signalling is mainly excitatory while OX2R can mediate both excitatory and 
inhibitory signals depending on the postsynaptic neurons (reviewed in Willie et al., 2001). 
Later, an interaction between OX1R and Gs or Gi has also been suggested (Holmqvist et al., 
2005; Magga et al., 2006). OX2R seems to bind both Ox-A and Ox-B in a non-selective 
manner while OX1R is substantially more selective to Ox-A (Sakurai et al., 1998). Both 
receptors are highly specific for orexin peptides and do not bind other neuropeptides 
(Holmqvist et al., 2001; Smart et al., 2001). In addition to the orexin peptides, neither full 
nor partial agonists of the receptors have been discovered or developed. However, 
several antagonists with distinct selectivities (e.g. SB-334867-A, SB-674042, TCS-OX2-29, 
JNJ-10397049 and ACT-078573) have been synthetized (Smart et al., 2001; Hirose et al., 
2003; Langmead et al., 2004; McAtee et al., 2004; Brisbare-Roch et al., 2007; for review see 
Boss et al., 2009) and at least one of them (SB-334867) seems to exert a partial agonist 
action (Bengtsson et al., 2007).  
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Figure 6. Amino acid sequences of human orexin-1 receptor (OX1R) (adapted from Kukkonen 
et al. 2002). Putative N-glycolysation sites, putative phosphorylation sites for cAMP-
dependent protein kinase (PKA), protein kinase C (PKC) and Ca2+/calmodulin-dependent 
protein kinase (CaMKII) and possible palmitoylated cysteines are shown. Grayscale coloring of 
the amino acids represents various amino acid families (nonpolar, polar with amide or 
hydroxyl group, acidic and basic). Additionally, cysteines (C) and methionines (M) are 
individually colored. 
2.3.3 Orexin System in the Central Nervous System and the Periphery  
Originally orexin peptides were detected almost exclusively in the brain except, for a 
small amount found in the testis (de Lecea et al., 1998; Sakurai et al., 1998). mRNAs of 
orexin and PPO were found from the cells of the lateral hypothalamus (de Lecea et al., 
1998; Sakurai et al., 1998). An exhaustive immunohistochemical study of PPO containing 
neurons and fibers in the rat brain conducted by Peyron et al. (1998) confirmed the 
localization of PPO immunoreactive neurons in the perifornical nucleus, the dorsomedial 
hypothalamic nucleus, and in the dorsal and lateral hypothalamic areas. Date et al. (1999) 
used specific antibodies for Ox-A and Ox-B and found that the same neurons express 
both peptides. The orexin neurons are organized bilaterally and symmetrically (Sakurai 
et al., 1998; Peyron et al., 1998). Some neurons in posterior hypothalamic areas, in the 
subthalamus (the zona incerta, subincertal, and subthalamic nuclei) and in dorsomedial 
hypothalamic nucleus also contain orexins (Sakurai et al., 1998; Peyron et al., 1998; 
Nambu et al., 1999; Date et al., 1999). The presence of orexin neurons has been confirmed 
in the brain of numerous species including rat, bovine, monkey, mouse, human, frog, and 
hamster (de Lecea et al., 1998; Sakurai et al., 1998; Elias et al., 1998; Broberger et al., 1998; 
Horvath et al., 1999a; 1999b; van den Pol, 1999; Galas et al., 2001; Mintz et al., 2001). 
Female rats seem to have a larger content of Ox-A peptide and OX1R mRNA in their 
hypothalamus than males (Taheri et al., 1999; Johren et al., 2001). The total number of 
orexin neurons has been estimated to be 6 700 in rat brain (Modirrousta et al., 2005) and 
70 000 in human brain (Thannickal et al., 2000).  
Orexin neurons have a relatively depolarized resting potential and they are 
spontaneously active regularly generating Na+-dependent action potentials (Li et al., 2002; 
Eggermann et al., 2003; Yamanaka et al., 2003b). The depolarized and active state of these 
cells is dependent on a constitutively active non-selective cation channel, most probably 
involving TRPC5 (Cvetkovic-Lopes et al., 2010). The activity of the neurons is modulated 
by neural inputs from diverse brain centres and by substances that enter the brain from 
the bloodstream (Li et al., 2002; Yamanaka et al., 2003a; 2003b; Sakurai T. et al., 2005; 
Yoshida et al., 2006). Orexin neurons express receptors for many neurotransmitters and 
neuromodulators (de Lecea and Sutcliffe, 2005) and some of these confer orexin neurons 
with a capability to detect hormonal signals related to the metabolic state of the organism. 
The same trend continues in the sensitivity of the orexin neurons to glucose (Muroya et 
al., 2001; Yamanaka et al., 2003a; Burdakov et al., 2005), triglycerides (Wortley et al., 2003; 
Chang et al., 2004), carbon dioxide and pH (Williams et al., 2007). Neuronal co-expression 
of certain neurotransmitters/hormones is considered as evidence for their involvement in 
the systemic effects for these substances. The orexin neurons have been suggested to co-
express dynorphin and galanin (feeding-regulating neuropeptides) (Hakansson et al., 
1999; Chou et al., 2001), glutamate (a most common excitatory neurotransmitter) 
(Abrahamson et al., 2001; Collin et al., 2003; Rosin et al., 2003; Torrealba et al., 2003), and 
prolactin (a hormone associated with reproduction and lactation) (Risold et al., 1999). 
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Although orexins are produced by only a small group of neurons, these neurons 
project to almost all brain areas (de Lecea et al., 1998; Peyron et al., 1998) as well as all 
levels of the spinal cord (van den Pol, 1999). The brain structures receiving dense 
projections from orexin neurons include the hypothalamus, olfactory bulb, cerebral 
cortex, thalamus, and brainstem (Peyron et al., 1998; Date et al., 1999; Horvath et al., 
1999b; van den Pol, 1999; Mondal et al., 1999a; 1999b; Shibata et al., 2008). It seems that 
the orexin neurons do not represent a homogenous cell population but the expression 
patterns and thereby the sensitivities to various substances vary among the cells 
(Hakansson et al., 1999; Muroya et al., 2001; Niimi et al., 2001). The heterogeneity of the 
orexin neurons is further emphasized by the distinct projection patterns of the various 
subgroups of neurons (Winsky-Sommerer et al., 2004; Espana et al., 2005). In all 
mammalian species examined, the distributions of orexin neurons and projections are 
very similar (Horvath et al., 1999b; Moore et al., 2001; Nixon and Smale, 2007)      
Furthermore, the receptors OX1R and OX2R were first detected exclusively in the brain 
(Sakurai et al., 1998). They are expressed in a pattern consistent with orexin nerve fibers 
(Trivedi et al., 1998; Lu et al., 2000; Hervieu et al., 2001; Marcus et al., 2001) in the 
hypothalamus, cerebral cortex, hippocampus, amygdala, and several nuclei of the 
subthalamus, thalamus, and brain stem. The distribution patterns of OX1R and OX2R are 
distinct, but partially overlapping (Trivedi et al., 1998; Marcus et al., 2001). This suggests 
different physiological roles for each receptor subtype. Hervieu et al. (2001) detected 
OX1R mRNA and protein also in the spinal cord and the dorsal root ganglia. Orexin 
neurons express OX2R and are directly activated by Ox-B as a positive-feedback signal 
(Yamanaka et al., 2010). 
The extensive study by Kirchgessner and Liu (1999) provided the first clue that orexins 
and their receptors might be expressed also in the peripheral tissues. Currently the 
presence of the peptides and/or receptors is firmly established at least in plasma, vagal 
afferent neurons, gastrointestinal tract and enteric nervous system directly controlling it, 
pancreas, adrenal gland, kidney, testis and ovaries (reviewed in Kirchgessner, 2002; 
Heinonen et al., 2008). The species tested include human, rat, mouse and guinea pig. 
There are also some indications that orexins and/or their receptors may be present in 
lung, heart, adipose tissue, placenta, thyroid gland, penis and epididymis (reviewed in 
Heinonen et al., 2008).    
2.3.4 Systemic Effects of Orexins 
The hypothalamus plays a key role in maintaining energy homeostasis and an 
appropriate state of arousal. It is a relay center of various metabolic, autonomic, 
endocrine and environmental factors and coordinates the behavioral, metabolic and 
neuroendocrine responses (Bernardis and Bellinger, 1993; 1996). The lateral 
hypothalamus, a region where there is extensive orexin expression, is especially 
important in food intake and behavioral arousal. Nevertheless, the diffuse nature of 
orexin projections suggests that there are multiple physiological roles for orexin peptides 
in addition to the initially suggested roles in feeding and sleeping (de Lecea et al., 1998; 
Sakurai et al., 1998) and furthermore, the detection of orexins and their receptors in the 
peripheral tissues extends the possible functions of these peptides. Table 2 illustrates the 
diversity of systemic functions proposed to be modified by orexins.  
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The first evidence for a physiological role of orexins in feeding behaviour came already 
from Sakurai et al. (1998), who showed that the central administration of Ox-A and Ox-B 
stimulated food consumption in the rats in a dose-dependent manner. Further studies 
from several research groups have verified the important role of Ox-A in the regulation 
of feeding behaviour. However, the results obtained with Ox-B are more variable and 
harder to interpret. Investigations with the selective OX1R antagonist (SB-334867-A) and 
with an anti-orexin antibody confirm that Ox-A acts endogenously to control natural 
eating behaviour (Haynes et al., 2000; Yamada et al., 2000; Rodgers et al., 2001). However 
the regulation seems to be complex and subject to diurnal variations (Haynes et al., 1999; 
Yamanaka et al., 1999). The total food intake during the chronic treatment with Ox-A 
does not change significantly and/or the body weight remains the same (Ida et al., 1999; 
Haynes et al., 1999; Yamanaka et al., 1999). Thus, the most important task of Ox-A in this 
context seems to be the initiation of food intake, but long-term energy homeostasis may 
be predominantly controlled by other factors than Ox-A. Some of the orexigenic effects 
might be mediated via other physiological responses evoked by orexins such as increased 
alertness and prolonged wakefulness or increased metabolic rate (Lubkin and Stricker-
Krongrad, 1998; Willie et al., 2001; Hara et al., 2001). Hypoglycemia has been shown to 
activate orexin neurons and this has been postulated to result in increased alertness and 
intensified search for food (Moriguchi et al., 1999; Cai et al., 2001; Yamanaka et al., 2003a; 
Burdakov et al., 2005; Burdakov and Alexopoulos, 2005). 
Central administration of orexins has been shown to increase wakefulness, decrease 
both slow-wave and REM sleep and disrupt sleep patterns (Hagan et al., 1999; Piper et al., 
2000; Bourgin et al., 2000; Methippara et al., 2000; Espana et al., 2001; Xi et al., 2001; 
Huang et al., 2001; Yamanaka et al., 2002). Adamantidis et al. (2007) developed an 
exceptional novel technique to artificially excite orexin neurons and showed that 
excitation produced an increase in the probability of transition from sleep to wakefulness 
during both slow-wave and REM sleep. Electrophysiological studies suggest that the 
effects of orexins on wakefulness and vigilance are induced by exciting histaminergic 
neurons in the tuberomammillary nucleus (Eriksson et al., 2001; Bayer et al., 2001; 
Yamanaka et al., 2002) and monoaminergic/cholinergic neurons in the brain stem nuclei 
(Hagan et al., 1999; Brown et al., 2001; Burlet et al., 2002). The neuronal activity of orexin 
neurons has been increased by administration of a wake-promoting therapeutic agent, 
modafinil (Chemelli et al., 1999; Scammell et al., 2000) or by short-term sleep deprivation 
(Estabrooke et al., 2001). The increased arousal induced by orexins is also apparent from 
the observations of behavioral studies showing that Ox-A and Ox-B increases locomotor 
activity especially in terms of the time spent grooming and searching, respectively 
(Hagan et al., 1999; Ida et al., 1999; 2000; Duxon et al., 2001). Orexin antagonists have 
been shown to promote sleep in animals and several compounds are currently being 
tested as potential drugs for treating insomnia (Scammell and Winrow, 2011). 
Collectively these results highlight the crucial role of orexins in triggering and 
maintaining alertness and wakefulness. In addition, the tight linkage of the orexin system 
to the circadian rhythm and the fact that, in rats, the orexin system is most active during 
the active dark phase (Date et al., 1999; Taheri et al., 2000; Abrahamson et al., 2001; 
Hervieu et al., 2001; Mikkelsen et al., 2001; Fujiki et al., 2001; Yoshida et al., 2001; 
Estabrooke et al., 2001) supports this conclusion.   
In the periphery, cells expressing orexins and/or their receptors are found primarily in 
the organs involved in feeding and energy metabolism (Kirchgessner, 2002; Heinonen et 
al., 2008) and the plasma levels of orexins are regulated by the nutritional status (Komaki 
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et al., 2001; Adam et al., 2002; Ehrstrom et al., 2005; Bronsky et al., 2007). Thus orexins are 
believed to have peripheral effects in controlling digestion and metabolism. Ox-A 
stimulates gastric acid secretion in stomach via the vagal pathway (Takahashi et al., 1999; 
Okumura et al., 2001; Ehrstom et al., 2005) and bicarbonate secretion in duodenum 
independently of vagal control (Flemstrom et al., 2003; Bengtsson et al., 2007). Orexins 
also seem to have an effect on intestinal motility but whether the effect is stimulatory or 
inhibitory is currently under debate due to the variability in the results (Heinonen et al., 
2008). The endocrine glands are another prominent group of peripheral tissues 
expressing orexins and/or their receptors (Kirchgessner, 2002; Heinonen et al., 2008). 
Orexins have been shown to regulate the secretion of numerous hormones related to 
energy metabolism, autonomic functions, stress responses, and reproduction both in the 
hypothalamus and in the periphery and consequently stimulatory and/or inhibitory 
effects of orexins on these systemic functions have been demonstrated (Willie et al., 2001; 
Sutcliffe and de Lecea, 2002; Kukkonen et al., 2002; Burdakov, 2007; Heinonen et al., 2008; 
Kuwaki, 2008; Carter et al., 2009).  
2.3.5 Diseases Linked to the Orexin System  
Narcolepsy/cataplexy is a disease characterized by excessive daytime sleepiness, episodes 
of muscle weakness and abnormalities of REM sleep. In large breed dogs, Doberman 
pinschers and Labrador retrievers, there have been reports of a familial disease caused by 
several mutations in the gene encoding for OX2R (Lin et al., 1999). Although the 
narcolepsy is usually considered as a non-genetic disease in humans, a firm link to the 
orexin system has been established by observations of dramatically reduced levels of Ox-
A in cerebrospinal fluid and a slightly decreased Ox-A concentration in the plasma of 
narcoleptic individuals (Nishino et al., 2000; Dalal et al., 2001; Ripley et al., 2001; Higuchi 
et al., 2002; Knudsen et al., 2010) and absence of orexin neurons in the lateral 
hypothalamus of post-mortem human narcoleptic brains (Peyron et al., 2000; Thannickal 
et al., 2000). The degeneration of hypothalamic orexin neurons detected in post-mortem 
studies (Peyron et al., 2000; Thannickal et al., 2000) and the strong association of a certain 
Human Leukocyte Antigen haplotype with narcolepsy (Honda et al., 1986b) indicates 
that narcolepsy might be an autoimmune disorder. A single case of human narcolepsy 
has been reported to be associated with a mutation in PPO, which probably impairs 
correct trafficking and processing of the peptide (Peyron et al., 2000). The involvement of 
the orexin system in the regulation of energy metabolism is supported by findings of a 
significantly higher average body mass index (Schuld et al., 2000; Nishino et al., 2001) 
and an elevated risk to develop type 2 diabetes (Honda et al., 1986a) of narcoleptic 
patients than age-matched control subjects, despite lower daily caloric intake. 
Interestingly, narcolepsy is also associated with olfactory dysfunction (Bayard et al., 2010). 
In addition to narcolepsy, the orexin system has been proposed to be involved in other 
disease states including obstructive sleep apnea syndrome, Parkinson’s disease, 
schizophrenia, depression and some types of cancer (de Lecea and Sutcliffe, 2005; 
Spinazzi et al., 2006; Carter et al., 2009). 
Chemelli et al. (1999) generated a PPO knock-out mouse model with a phenotype 
strongly resembling human and canine narcolepsy. These mice exhibit reduced activity 
during the dark phase, behavioural arrests and disruption of REM sleep regulation. In 
addition to regulation of sleep/wake cycle and vigilance, the phenotype of PPO knock-
out mice also provided support for some of the other putative systemic functions of 
orexins. PPO knock-out mice display a diminished behavioural response to stressful 
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stimuli (Georgescu et al., 2003; Kayaba et al., 2003), have a lower basal blood pressure 
(Kayaba et al., 2003) and a decreased chemosensitivity to carbon dioxide (CO2) during 
wakefulness (Deng et al., 2007) than their wild-type littermates. Transgenic animals eat 
less than their wild-type counterparts but still maintain the same body weight, implying 
that there is a difference in energy homeostasis and metabolic rate (Willie et al., 2001). 
Single receptor knock-out mouse models have been generated in order to unravel the 
possible distinct involvement of orexin receptor subtypes in the systemic effects induced 
by the orexins. However, the appearance of compensatory systems may well complicate 
the interpretation of the results. OX1R knock-out mice exhibit no overt behavioural 
changes except for more rapid cycling between vigilance states whereas OX2R knock-out 
mice suffer from a mild narcoleptic disorder (Willie et al., 2001). Double receptor knock-
out mice and PPO knock-out mice seem to have the exactly same phenotype (Willie et al., 
2001). Thus, it seems that both receptor subtypes participate in regulation of sleep/wake 
cycle and severe narcolepsy develops only with the disruption of both subtypes.  
Hara et al. (2001) created an interesting mouse model for following the possible 
progression of human narcolepsy. In these mice, the orexin neurons are specifically and 
progressively ablated. Consequently, the mice display behavioral arrests, disrupted REM 
sleep and a poorly consolidated sleep pattern. There are several findings indicating that 
there have been changes in the basal metabolism and the energy homeostasis of these 
animals. The transgenic mice suffer from late-onset obesity and have an elevated risk for 
type 2 diabetes, despite eating less than the control animals (Hara et al., 2001). 
Additionally they fail to respond with normal vigilance and locomotor activity to fasting 
(Yamanaka et al., 2003a). The abnormalities in the emotional state-dependent adjustment 
of the central autonomic regulation on circulation and respiration observed in these mice 
point to an essential role for the orexin system in controlling autonomic functions and 
emotional behaviours (Kuwaki, 2011). Central administration of Ox-A can reduce 
cataplexy and prolong the wake time in these animals (Mieda et al., 2004). Similarly, an 
improvement in the condition of narcoleptic dogs after systemic administration of Ox-A 
has been reported (John et al., 2000), although another research group was unable to 
confirm this finding (Fujiki et al., 2003).   
2.3.6 Cellular Effects of Orexins 
The basis of all the systemic effects of orexins listed above is the cellular responses 
induced by orexin peptides binding to either of the two orexin receptors. Activation of 
orexin receptors have been shown to activate a wide variety of intracellular signalling 
pathways.  
 
Neuronal Excitation 
Orexin peptides reside in the synaptic vesicles in axon terminals of orexin neurons and 
are released in response to excitation of the cells (de Lecea et al., 1998; Peyron et al., 1998; 
Horvath et al., 1999a). They have been reported to have actions on presynaptic neurons 
and also at postsynaptic sites (van den Pol et al., 1998; Burlet et al., 2002; Acune-Goycolea 
and van den Pol, 2009). Generally, orexin peptides are believed to be excitatory and to 
increase the neuronal electrical activity of the receptive neuron. Already in the first report 
describing orexins, a prominent excitatory effect was observed i.e. an increase in the 
frequency of postsynaptic currents in 75 % of the synaptically coupled rat hypothalamic 
neurons (de Lecea et al., 1998). Later, orexins have been shown to excite several types of 
target neurons in various brain regions including many areas and nuclei of 
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hypothalamus (Liu et al., 2001; Bayer et al., 2001; Eriksson et al., 2001; Yamanaka et al., 
2002; Samson et al., 2002; Acuna-Goycolea and van den Pol, 2009; Klisch et al., 2009), 
thalamus (Govindaiah and Cox, 2006; Huang et al., 2006), brain stem (Hagan et al., 1999; 
Bourgin et al., 2000; Hwang et al., 2001; Burlet et al., 2002; Takahashi et al., 2002; Liu et al., 
2002; Brown et al., 2002; Korotkova et al., 2002; Yang and Ferguson, 2002; 2003; Yang et al., 
2003; Grabauskas and Moises, 2003; Soffin et al., 2002; 2004; Takahashi et al., 2005; 
Muschamp et al., 2007), forebrain (Eggermann et al., 2001; Wu M. et al., 2002; 2004; Kolaj 
et al., 2008; Arrigoni et al., 2010), and cortex (Song et al., 2005; Xia et al., 2005a), as well as 
in spinal cord (Antunes et al., 2001; van den Top et al., 2003) and in peripheral tissues 
(Kirchgessner and Liu, 1999). This extensive collection of electrophysiological data 
provides support for the roles of orexins in the regulation of various physiological 
functions such as feeding, cardiovascular functions, sexual behavior, wakefulness, 
attention, gastric acid secretion, gut motility, and endocrine secretion.  
 Excitation of the target neurons via postsynaptic effects is evident from membrane 
depolarization, increased firing rate, prolonged firing, and/or enhanced inward current. 
Very often the primary mechanism behind excitation has been postulated to be a closure 
of potassium channels (van den Top et al., 2003; Grabauskas and Moises, 2003; Wu et al., 
2004; Xia et al., 2005a; Govindaiah and Cox, 2006; Huang et al., 2006; Kolaj et al., 2008), 
but there may also be involvement of an activation of Na+/Ca2+ exchanger (Eriksson et al., 
2001; Wu M. et al., 2002; 2004; Acuna-Goycolea and van den Pol, 2009) or nonselective 
cation channel (Hwang et al., 2001; Liu et al., 2002; Brown et al., 2002; Yang and Ferguson, 
2002; 2003; Huang et al., 2006; Kohlmeier et al., 2008). Probably the excitation results from 
more than one cellular mechanism. The intracellular second messengers: Gi/o-proteins 
(van den Top et al., 2003), PLC (Yang et al., 2003; Xia et al., 2005a; Song et al., 2005), PKC 
(Yang et al., 2003; Xia et al., 2005a; Song et al., 2005), and/or PKA (Korotkova et al., 2002; 
van den Top et al., 2003) have been proposed to lie along the signalling pathways leading 
to excitation. Presynaptic excitation caused by stimulation of orexin receptors induces 
increased release of neurotransmitters: glutamate (van den Pol et al., 1998; Kodama and 
Kimura, 2002; John et al., 2003; Borgland et al., 2008), GABA (van den Pol et al., 1998; Wu 
M. et al., 2002; Viggiano et al., 2004), noradrenaline (Hirota et al., 2001, Walling et al., 
2004), histamine (Huang et al., 2001; Ishizuka et al., 2002; 2006; Hong et al., 2005), 
serotonin (Tao et al., 2006), and acetylcholine (Bernard et al., 2003; 2006; Fadel et al., 2005). 
The mechanisms accounting for the presynaptic actions of orexins remain largely 
unknown, but may involve the influx of extracellular Ca2+ (Hirota et al., 2001; John et al., 
2003) and PKC (Borgland et al., 2008).  
Some inhibitory effects of orexins on neuronal activity have also been reported. Ox-A 
significantly suppresses glucoreceptor neurons in the ventromedial hypothalamic 
nucleus, a brain area which is believed to mediate the cessation of eating (Shiraishi et al., 
2000). This is probably one way through which Ox-A can stimulate feeding. Orexins seem 
to have both inhibitory and excitatory effects on neurons of the hypothalamic 
suprachiasmatic nucleus, which is the main circadian pacemaker in the brain (Brown et 
al., 2008; Klisch et al., 2009). Orlando et al. (2001) demonstrated an inhibitory presynaptic 
effect of orexins on the depolarization-stimulated release of serotonin. 
 
Increase in Intracellular Calcium Concentration 
Another well characterized cellular response evoked by stimulation of orexin receptors is 
the dose-dependent transient increase in [Ca2+]i, which was already observed by Sakurai 
et al. (1998) in Chinese hamster ovary cells (CHO-K1) and HEK293 cells stably transfected 
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with OX1R. Both orexin peptides acting on either of the two receptors are able to elicit a 
Ca2+ response in recombinant cell models (Sakurai et al., 1998; Smart et al., 1999; Lund et 
al., 2000; Okumura et al., 2001; Holmqvist et al., 2002; Ammoun et al., 2003) as well as in 
native systems, such as cultured neurons from the rat lateral and medial hypothalamus 
(van den Pol et al., 1998), the rat tuberomammillary nucleus (Eriksson et al., 2001), the rat 
arcuate nucleus (Muroya et al., 2004), the murine midbrain (Narita et al., 2007), the rat 
spinal cord (van den Pol, 1999), the rat dorsal root ganglion (Ozcan et al., 2010), and the 
ovine pituitary gland (Xu et al., 2002; 2003). Furthermore, Ox-A has been shown to induce 
an increase in [Ca2+]i in duodenal enterocytes isolated from the rat duodenal mucosa or in 
biopsy specimens of human duodenum (Bengtsson et al., 2009), in brain slices from the 
murine laterodorsal tegmentum and dorsal raphe (Kohlmeier et al., 2004; 2008), in 
dopamine neurons isolated from the rat ventral tegmental area (Nakamura et al., 2000; 
Uramura et al., 2001), in primary cultured neurons from the rat spinal cord (Xia et al., 
2005b) and in cell lines of intestinal neuroendocrine cells (STC-1) (Larsson et al., 2003) as 
well as in pancreatic tumor cells (AR42J) (Harris et al., 2002). Consequently, there are 
clear indications for a physiological relevance of the Ca2+ response induced by orexins in 
endogenous systems.  
Coupling of orexin receptors to the Gq/11 subgroup of G-proteins (Sakurai et al., 1998; 
van den Pol et al., 1998; Randeva et al., 2001; Zhu et al., 2003) indicates that the 
stimulation of the receptor activates PLC -pathway leading to Ca2+ release from the 
intracellular stores and subsequent CCE from the extracellular space. Several studies 
have confirmed the activation of this signalling pathway (Smart et al., 1999; Kukkonen 
and Akerman, 2001; Muroya et al., 2004; Ekholm et al., 2007; Johansson et al., 2007; 2008). 
However, when lower, and probably a more physiological concentration of Ox-A or Ox-B 
has been used, the Ca2+ response is acutely dependent on the extracellular Ca2+ 
concentration pointing to the involvement of Ca2+ influx instead of release of the cation 
from its storage sites (Lund et al., 2000; Ammoun et al., 2003; Magga et al., 2006). The 
importance of Ca2+ influx as a primary response is also evident from the results 
demonstrating that membrane depolarization which decreases the driving force of Ca2+ 
influx, is able to abolish the Ca2+ response (Lund et al., 2000) and that attenuation of IP3 
elevation and Ca2+ release from the intracellular stores leaves the Ca2+ influx untouched 
(Ekholm et al., 2007). The ROCs and SOCs activated after OX1R stimulation have different 
pharmacological profiles implicating the involvement of distinct molecular entities 
(Kukkonen and Akerman, 2001) and OX1R seems to activate ROCs through a signalling 
pathway independent of Gq/11-protein activation (Magga et al., 2006). Based on these 
results, a signalling model has been proposed in which the receptor-operated Ca2+ influx 
is the primary response and IP3 production, Ca2+ release and CCE are subsequent to this 
response after potentiation of PLC activity by Ca2+ influx (Lund et al., 2000; Kukkonen 
and Akerman, 2001). Johansson et al. (2007) provided further proof for the model by 
demonstrating the central role of the receptor-activated Ca2+ influx in amplifying the 
OX1R induced PLC response. Thus at a low concentration of Ox-A, Ca2+ influx is required 
to sufficiently activate PLC and produce IP3. On the other hand, if OX1R is prevented 
from coupling to the receptor-activated Ca2+ influx pathway, the receptor can utilize other 
Ca2+ influx pathways to activate Ca2+-dependent downstream processes (Ammoun et al., 
2006a). Also CCE is capable to amplify PLC response (Johansson et al., 2007). Later, it has 
been shown that OX1R is capable of activating various phospholipases depending on the 
Ox-A concentration stimulating the receptor (Johansson et al., 2008). At the lowest 
concentration of Ox-A capable of inducing a Ca2+ response, PLD is activated and the the 
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second messengers most likely produced are DAG and PA. At 10-100-fold higher 
concentration, an activation of PLC can be also detected, but the production of IP3 is still 
absent. Finally, still higher concentrations of Ox-A probably activate a different type of 
PLC, which hydrolyses PIP2 to produce DAG and IP3 (Johansson et al., 2008). Thus, the 
present model completely excludes the involvement of PLC -pathway at low 
concentrations of Ox-A with the response being solely derived from the Ca2+ influx. The 
differential coupling of OX1R to phospholipases clearly explains the differences in Ca2+ 
signalling observed at low and high concentrations of Ox-A. At high concentration of Ox-
A, OX1R behaves like a classical Gq/11-coupled receptor while at low concentrations, an 
activated Ca2+ channels is sufficient to elicit cellular responses.  
Ca2+ influx, which is dependent on the extracellular Ca2+ concentration ([Ca2+]o) and 
mediated via a similar non-voltage-gated Ca2+ channels as the one characterized in stably 
transfected nonexcitable CHO-K1 and HEK293 cells also seems to be the primary 
response to OX1R stimulation in recombinant neuron-like cell systems (Neuro-2A murine 
neuroblastoma cells and PC12 human pheochromocytoma cells) (Holmqvist et al., 2002). 
In native systems, orexins induce increased Ca2+ current which is often considered a 
response indendent of the store release (van den Pol et al., 1998; Eriksson et al., 2001; Xu 
et al., 2002; 2003; Kohlmeier et al., 2004; 2008; Xia et al., 2005b). Kohlmeier et al. (2004) 
observed Ca2+ oscillations among other response types after Ox-A stimulation of young 
mouse brain slices taken from the laterodorsal tegmentum and the dorsal raphe. The Ca2+ 
responses were derived from the PKC-dependent Ca2+ influx via L-type VOCs and not 
dependent on Ca2+ release from the intracellular store. Also other reports have proposed 
the involvement of L-type channels (Uramura et al., 2001; Xu et al., 2002; 2003; Larsson et 
al., 2003) and the importance of PKC (van den Pol et al., 1998; Uramura et al., 2001; Xu et 
al., 2002; 2003; Kohlmeier et al., 2008; Ozcan et al., 2010) in the generation of orexin 
induced Ca2+ responses in neuronal systems. Thus the signalling sequence leading to Ca2+ 
elevation in neurons seems to consist of activation of the orexin receptor and PLC, the 
production of DAG, the activation of PKC and finally phosphorylation of the L-type 
channel by PKC, leading to channel opening. Nonexcitable cells, which have been widely 
used as model systems to study signalling of orexin receptor do not express VOCs, and 
therefore the molecular entity responsible for the receptor-activated Ca2+ influx has to be 
different.  
Although in most systems orexins have been reported to increase the [Ca2+]i, there are 
also exceptions. Ox-A and Ox-B have attenuated Ca2+ oscillations and decreased [Ca2+]i 
levels in isolated propiomelanocortin-containing neurons from the rat arcuate nucleus. 
The effect is probably mediated via OX2R and Gi/o-proteins (Muroya et al., 2004). Orexins 
also decrease [Ca2+]i levels of glucose-responsive neurons in the rat ventromedial 
hypothalamus (Muroya et al., 2004). It is possible that orexins do not elevate Ca2+ in all 
cell types or that other signals generated by the receptor activation counteract Ca2+ 
elevation. 
   
Adenylyl Cyclase Pathway 
In both recombinant cell lines and native cells, orexin receptor activation has been shown 
to lead to the activation of AC and production of cAMP, which in turn can activate PKA 
(Malendowicz et al., 1999; Mazzochi et al., 2001b; Randeva et al., 2001; Nanmoku et al., 
2002; Holmqvist et al., 2005; Karteris et al., 2005; Ammoun et al., 2006a; Gorojankina et al., 
2007; Tang et al., 2008). The orexin-evoked activation of the AC pathway is significant in 
the adrenal gland, where orexins stimulate secretion of glucocorticoids from 
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adrenocortical cells through cAMP-dependent process (Malendowicz et al., 1999; 
Mazzochi2001b; Ziolkowska et al., 2005). On the other hand, many studies using different 
models and methods have failed to detect the orexin induced activation of AC or the 
elevation of cAMP or to link the AC pathway to the cellular responses induced by orexins 
(van den Pol et al., 1998; Samson and Taylor, 2001; Mazzochi et al., 2001a; Harris et al., 
2002; Xu et al., 2002; 2003; Larsson et al., 2003; Yang et al., 2003; Chen and Randeva, 2004; 
Kohlmeier et al., 2004; Magga et al., 2006). Thus this response seems to be rarer and more 
cell type/tissue specific than for example, the Ca2+ response. This becomes more 
conceivable when bearing in mind the possible tissue specific expression of different AC 
isoforms and G-protein subtypes. Interestingly, Mazzochi et al. (2001a) demonstrated that 
orexins utilize different signalling pathways in pheochromocytoma to stimulate 
catecholamine release and in normal adrenal tissue to increase glucocorticoid secretion. 
The PLC -pathway is predominant in the former response while AC-pathway is used in 
the latter case.  
Orexins can also have other than stimulatory roles in AC signalling. Zhu et al. (2003) 
presented the inhibitory effect of activated OX2R on forskolin stimulated AC activation. 
Steidl et al. (2004) and Goncz et al. (2008) demonstrated the decrease of cAMP level after 
Ox-A treatment in hamster glucagon-secreting -cells and primary human hematopoietic 
stem/progenitor cells, respectively. Although the orexins seem to increase AC activity in 
adrenal cortical cells (Malendowicz et al., 1999; Mazzochi et al., 2001b; Nanmoku et al., 
2002), the effect is opposite in adrenal medulla cells where Ox-A decreases the cAMP 
level (Nanmoku et al., 2002). Thus it seems that the regulation of the activity of AC by 
OX1R occurs via multiple pathways. The receptor can couple to Gi/o-protein to inhibit 
cAMP generation, to Gs-protein to stimulate cAMP generation and to Gq/11-protein to 
activate PLC -pathway leading to activation of PKC, which in turn can stimulate cAMP 
generation (Holmqvist et al., 2005).  
 
Activation of Protein Kinases 
Orexins have been demonstrated to activate several types of protein kinases including 
PKC, PKA, MAPKs, adenylate-cyclase-kinase and phosphoinositide-dependent kinase 1 
(Kukkonen et al., 2002; Holmqvist et al., 2005; Milasta et al., 2005; Ammoun et al., 2006a, 
2006b, Ekholm et al., 2007; Tang et al., 2008; Ramanjaneya et al., 2009; Goncz et al., 2008). 
As described above, the activation of PKA and PKC has been proposed based on the 
indirect data showing the activation of PLC - and AC-pathways by orexins and 
demonstrating the effects of specific inhibitors on orexin induced responses. The exact 
subtypes activated by orexins have not yet been identified, but Holmqvist et al. (2005) 
were able to suggest the activation of PKC  based on their experiments with 
pharmacological inhibitors.  
Several studies have examined the specific activation of MAPKs: ERK1, ERK2 and p38, 
but not ERK5 and c-Jun N-terminal kinase, by both Ox-A and Ox-B (Kukkonen et al., 
2002; Milasta et al., 2005; Ammoun et al., 2006a; 2006b; Ekholm et al., 2007; Tang et al., 
2008; Ramanjaneya et al., 2009). The response might be mainly transmitted through OX1R, 
but also a role for OX2R in activation of ERK1/2 and p38 has been suspected (Tang et al., 
2008; Ramanjaneya et al., 2009). The studies on activation mechanisms point to the 
involvement of multiple G-proteins and signalling pathways. The main pathways leading 
to activation of MAPKs seem to be Gq/PLC/PKC and Gs/AC/cAMP/PKA, but also the 
involvement of Gi-protein has been implicated (Tang et al., 2008; Ramanjaneya et al., 
2009). The predominance of a signalling pathway depends on the peptide (Ox-A or Ox-B) 
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stimulating the receptor, the receptor subtype (OX1R or OX2R) which is activated and the 
cellular environment. In addition to the above pathways, also small GTP-binding protein 
Ras, phosphoinositide-3-kinase and protein kinase Src are thought to participate in 
signalling leading to activation of ERK1/2 (Ammoun et al., 2006a). Ca2+ influx seems to 
have a central role, because inhibition of influx pathways can fully attenuate ERK 
phosphorylation (Ammoun et al., 2006a). Inhibition of IP3 elevation and consequent Ca2+ 
release from the intracellular stores do not affect the ERK response indicating that the 
effect is not solely due to the increase in [Ca2+]i but the influx of the cation is required 
(Ekholm et al., 2007).  
MAPKs can regulate both cell proliferation and apoptosis and orexins seem to play a 
dual role in the regulation of cell survival. In a recombinant cell system, Ammoun et al. 
(2006b) demonstrated that Ox-A caused a delayed cell death independently of the 
elevation of [Ca2+]i and signalling molecules generally associated to apoptosis, p53 and 
caspase. Activity of p38 was essential for induction of apoptosis, while the ERK pathway 
was protective. Spinazzi et al. (2005) investigated the role of Ox-A in the proliferation of 
cultured adrenocortical cells endogenously expressing orexin receptors. They found that 
Ox-A stimulates cell proliferation via OX1R and MAPK p42/p44, while Ox-B inhibits it via 
OX2R and p38.  
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3 Aims of the Study  
The physiologically prominent role of orexin signalling in the human body is widely 
acknowledged. Many cellular effects of orexins like elevation of [Ca2+]i and activation of 
protein kinases have been repeatedly reported, but the signalling pathways leading to 
these responses have not been fully identified or characterized. However, the detailed 
knowledge of the signalling inside the cell is critical if one wishes to understand the 
effects of orexins at the systemic level and to interfere with the orexin system in order to 
treat the orexin-related disorders. This study was carried out to elucidate the signalling 
pathways activated by the stimulation of OX1R. The specific aims of the present study 
were: 
 
1. To recognize various cellular responses induced by stimulation of OX1R by Ox-A 
2. To characterize Ca2+ responses induced by different concentrations of Ox-A in several 
recombinant cell models 
3. To identify signalling pathways participating on the regulation of Ox-A induced Ca2+ 
responses 
4. To elucidate which Ca2+ channels are responsible for the Ca2+ influx induced by low 
concentration of Ox-A  
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4 Materials and Methods  
4.1 CELL CULTURE (I-IV) 
The cell lines used in this study were based on Chinese hamster ovarian CHO-K1 cells (I), 
human embryonic kidney HEK293 cells (III, IV) and human neuroblastoma IMR32 cells 
(II). All the cell lines were obtained from American Type Culture Collection. CHO-K1 
cells are a widely used recombinant cell model to explore signalling pathways activated 
by GPCRs. However, this cell line has been derived from a rodent species and in order to 
acquire results which would be more relevant in human tissues, the HEK293 cell line is 
often used. Both CHO-K1 and HEK293 cells are non-excitable. As a model of excitable 
cells, the neuroblastoma cell line IMR32 was used. It is an adrenergic human cell line that 
can be differentiated in vitro to extend long axon-like processes with numerous growth 
cones (Clementi et al., 1986; Carbone et al., 1990) and thus provides a model of mature 
neurons in human. 
The CHO-K1 and HEK293 cell lines were transfected to stably express the human 
OX1R. The generation of CHO-hOX1-C1 cells (I) has been described by Lund et al. (2000). 
CHO-hOX1-C1 cells were cultured in Ham’s F-12 cell culture medium supplemented with 
100 units/ml penicillin G, 80 units/ml streptomycin, 400 g/ml geneticin, and 10 % fetal 
bovine serum (FBS). HEK293OX1R (III, IV) cells were prepared essentially the same way 
as HEK-OX1-FLAG as described by Magga et al. (2006). HEK293OX1R cells were cultured 
in Dulbecco’s Modified Eagle’s cell culture medium supplemented with 100 units/ml 
penicillin-streptomycin, 0.05 mg/ml hygromycin, and 10 % FBS. Successful transfections 
of CHO-hOX1-C1 and HEK293OX1R cells were confirmed by functional studies. Low 
nanomolar concentrations of Ox-A were sufficient to induce robust Ca2+ responses in 
these cell lines. In single cell Ca2+ imaging recordings, all stably transfected cells 
responded to Ox-A, while no responses even at high concentrations of Ox-A (1 M) were 
detected in non-transfected cell lines. IMR32 cells (II) were grown in standard Minimum 
Essential cell culture medium with 100 units/ml penicillin-streptomycin, and 10 % FBS. 
The cell cultures were grown in 260 ml culture flasks (Nunc A/S) in an air-ventilated 
humified incubator (37 °C, 5 % CO2). All the cell lines were cultured continuously and 
when the cultures reached 80 – 100 % confluency, the cells were detached by using 
phosphate-buffered saline containing 0.2 g/l ethylenediaminetetraacetic acid and 
transferred to new cell culture bottles with fresh medium.   
4.2 POLYMERASE CHAIN REACTION ASSAYS 
4.2.1 mRNA of Transient Receptor Potential Channels in CHO-hOX1-C1 cells (I) 
Total RNA (0.5 g) was extracted from the cells using TRIzol (Invitrogen), reverse-
transcribed to make cDNA using the SuperscriptII cDNA synthesis kit (Invitrogen) and 
amplified by using general trpc-specific degenerate primers 5’-nggvmchytgcagathtc-3’ 
and 5’-nckhgcaaayttccaytc-3’. The polymerase chain reaction (PCR) was as follows: 95 °C 
for 5 min, 50 °C for 30 s, 72 °C for 30 s, and 94 °C for 30 s, 30 cycles. Amplified DNA was 
gel-purified and inserted into a PgemTeasy plasmid (Promega) and sequenced. PCR 
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product identification was done using BLAST (basic local alignment search tool) program 
(Altschul et al., 1997).  
For expression analysis, specific primers for each trpc mRNA subtype were designed 
and tested. Nucleotide sequences, retrieved from the GenBankTM data base, were 
aligned with MacMolly Tetra (version 3.10, align ppc program, Soft Gene GmbH). The 
primers are presented in Table 3. 
PCR conditions were optimized. The optimal annealing temperature for trpc1, trpc3, 
trpc6 and trpc7 was 55 °C and for trpc2, trpc4 and trpc5 59.5 °C. One or 0.5 l (trpc1/trpc2) 
of the 20 l cDNA reaction was amplified with channel-specific primers using optimized 
conditions. Identical amounts of PCRs were run on a 1.5 % agarose Tris-Borate-EDTA gel, 
stained with SYBRgreenI (Molecular Probes) according to the manufacturer’s instructions, 
and scanned on a Storm 860 imaging system (Amersham Biosciences). Quantification of 
signal was done using ImageQuant program. 
 
Table 3. Primer pairs for detection of trpc channels in CHO-hOX1-C1 cells 
Channel subtype Primer sequence 
TRPC1-5’ 
TRPC1-3’ 
CTTGTTCTGTTTTCCTTCAC  
AAGCAGGTGCCAATGAACGA 
TRPC2-5’ 
TRPC2-3’ 
TCATCCTGACTGCCTTCC 
CCAGGAACTGAGGCATGT 
TRPC3-5’ 
TRPC3-3’ 
ACTACCTTGGGGCCAAAG 
CTACATCACTGTCATCCTC 
TRPC4-5’ 
TRPC4-3’ 
GTGGAGAAGGGGGACTATGC 
CCACGGCTCCAACCACCT 
TRPC5-5’ 
TRPC5-3’ 
TCCCTCTACCTGGCAACT 
AAAGAGCGTGGAGAAGGC 
TRPC6-5’ 
TRPC6-3’ 
CTCTGAAGGTCTTTATGC 
TCATCCTCAATTTCCTGG 
TRPC7-5’ 
TRPC7-3’ 
GCTGAAATACGACCACAA 
ATGAGGCACATCTTGATTC 
4.2.2 mRNA of Transient Receptor Potential Channels in differentiated IMR32 cells (II) 
IMR32 cells were differentiated for 6, 8, and 10 days. Total RNA (5 g) was extracted 
using TRIzol (Invitrogen) and reverse-transcribed to make cDNA using SuperscriptII and 
oligo-dT (Invitrogen). An aliquot of the first-strand cDNA template (approximately the 
equivalent of 250 ng total RNA) was amplified with an annealing temperature of 55 °C 
for 30 cycles with Dynazyme II (Finnzymes, Espoo, Finland) using the specific primers 
presented in Table 4. 
The primers were designed according to sequences available from the European 
Biology Laboratory database and at least one intron region was included to avoid 
amplification of genomic DNA and unprocessed RNA. The PCR reactions were 
electrophoretically analyzed on 2 % agarose gels and stained with ethidium bromide, and 
images were collected using a GelDoc imaging system (Bio-Rad). Amplified DNA 
fragments were gel purified and ligated into pGemTeasy (Promega) and sequenced. 
Sequences were identified using the BLAST program (Altschul et al., 1997). 
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Table 4. Primer pairs for detection of trpc channels in IMR32 cells 
Channel subtype Primer sequence 
TRPC1–5’ 
TRPC1–3’ 
GGGTCCATTACAGATTTCAA 
AAGCAGGTGCCAATGAACGA 
TRPC3–5’ 
TRPC3–3’ 
GTATGTGGACAGTTACGTC 
CTACATCACTGTCATCCTC 
TRPC4 –5’ 
TRPC4 –3’ 
TGGGATGGCGGACTTCAG 
ATGCCTTTGCAGGTTAACCC 
TRPC5–5’ 
TRPC5–3’ 
GTGGAGAAGGGGGACTATGC 
CCTCACTTGATAAGGCAATG 
TRPC6 –5’ 
TRPC6 –3’ 
CTCTGAAGGTCTTTATGC 
TCATCCTCAATTTCCTGG 
TRPC7–5’ 
TRPC7–3’ 
AACCCAGCGTTTACAACG 
ATGAGGCACATCTTGATTC 
4.2.3 mRNA of Protein Kinase Ds in HEK293OX1R cells (IV) 
Total RNA (5 g) was extracted from the cells using TRIzol (Invitrogen), reverse-
transcribed to make cDNA using Revertaid (Fermentas) and amplified using Dynazymes 
(Finnzymes) and specific primers: PKD1 5’-GCCAGCTTCGTAATGAGG-3’/5’-
CCTGCCCTTTTCACTTGA-3’, PKD2 5’-CGCTCTTCCAGAACAACACG-3’/5’-
ACGAAGTAGGTGGCATTGG-3’, and PKD3 5’-CATGCCTGTTACTCCTCAAGC-3’/5’-
AACTGGCCTGAACCAAGC-3’. The primers were designed using eprimer3 (EMBOSS). 
PCR conditions were as follows: 95 °C for 5 min, 94 °C for 20 s, 72 °C for 20 s, and 55 °C 
for 20 s, 30 cycles. PCR reactions were purified and sequenced using the ABI-prism 
system. Sequences were identified using the BLAST program (Altschul et al., 1997). 
4.3 MEASUREMENTS OF ARACHIDONIC ACID RELEASE (III) 
HEK293OX1R cells were cultured on poly-L-ornithine-coated 24-well plates to 50 % 
confluence. 0.1 Ci [3H]-AA ([5,6,8,9,11,12,14,15-3H]-arachidonic acid, New England 
Nuclear Corp. GesmbH) was added in each well and the cells were cultured for another 
20 h. The incubation medium was removed and the cells were washed twice with the 
culture medium without serum but supplemented with 2 mg/ml bovine serum albumin. 
The stimulations with Ox-A were performed at 37 °C in 250 l/well of this same medium. 
After 7 min of stimulation, 200 l of the medium from each well was transferred to an 
Eppendorf tube on ice. These samples were spun down for 1 min at 4 °C and 150 l of the 
medium was transferred to a scintillation tube and the scintillation cocktail (HiSafe3, 
Wallac-PerkinElmer) was added. Cell remnants on the 24 well plates were dissolved in 
0.1 M NaOH and the scintillation cocktail was added. The radioactivity was counted in a 
scintillation counter after allowing the samples to set for 24 h.  
4.4 TRANSFECTIONS AND TRANSDUCTIONS   
4.4.1 DNA Constructs (I, III, IV) 
Truncated forms of five trpc channels (trpc1, trpc2, trpc3, trpc4 and trpc7) exerting 
dominant negative effects as well as functional trpc3 channel were constructed by a 
standard protocol by subcloning a restriction fragment of desired size from a parent 
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vector into digested target vector (Table 5, Figure 7). Verification that all constructs were 
correct and inframe with enhanced green/yellow fluorescent protein (EGFP/EYFP) was 
done by automated sequencing.  
 
Table 5. Construction of truncated forms of trpc1, trpc2, trpc3, trpc4 and trpc7 and functional 
form of trpc3 
Construct Parent vector 
(restriction) 
Fragment 
size (bp) 
Target vector 
(restriction) 
mtrpc1 N-EGFP-N3 
(trpc1N) 
pcDNAtrpc1 FLAG1 
(NsiI-BamHI) 
1480 pEGFP-N32 
(BglII-PstI) 
mtrpc2N-EGFP-N1 
(trpc2N) 
pcDNA-mtrpc2 clone 143 
(BamHI-PstI) 
2552 pEGFP-N12 
(BglI-PstI) 
EYFP-hstrpc3N-C1 
(trpc3N) 
human trpc3 cDNA4 
(BamHI-StuI, partial digest) 
1620 pEYFP-C12 
(BglII-SmaI) 
functional trpc3 
channel5 (TRPC3FLAG) 
human trpc3 cDNA4 
(BamHI-SpHI) 
 pIRES-hrGFP1a6 
EYFP-mtrpc4 dn-C1 
(trpc4N) 
mtrpc4 -stop-EYFP 
(SalI-EcoRV)7 
1520 pEYFP-C12 
(SalI-SmaI) 
mtrpc7 dn-EGFP-N1 
(trpc7N) 
PCIneomtrpc7 8 
(NheI-SacII) 
1485 pEGFP-N12 
(BglI-PstI) 
1Gift from J. Frey (Engelke et al., 2002), 2(BD Biosciences), 3gift from L. Birnbaumer (Vannier 
et al., 1999), 4gift from C. Harteneck (Hofmann et al., 1999), 5the last three residues are 
replaced by a triple FLAG epitope tag, 6(Stratagene), 7gift from M. Nowycky (Obukhov and 
Nowycky, 2002), 8gift from T. Okada (Okada et al., 1999). 
 
Figure 7. Schematic representation of truncated trpc channel constructs (Graphics by J. 
Peltonen). N-terminus of TRPC channels contains repeated ankyrin domains and a coiled-coil 
domain (CC). The channels have 6 transmembrane (TM) domains and the pore region is 
located between the fifth and sixth TM domain. C-terminus may display domains binding to 
inositol 1,4,5-trisphosphate receptor (IP3R), calmodulin (CaM) and PDZ-domains (Clapham, 
2003). In truncated channel constructs, the N-terminus of the channel is intact, but the pore 
region and the C-terminus have been deleted. Constructs are tagged with enhanced 
green/yellow fluorescent protein (EGFP/EYFP).  
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Trpc6DN exerting a dominant negative effect was a gift from T. Gudermann (Hofmann et 
al., 2002). Kinase dead PKD constructs, PKD1K612W and PKD3K605A, used in this study 
were gifts from A. Hausser (Hausser et al., 2002) and O. Rey (Rey et al., 2006a), 
respectively. These constructs are called kinase dead, because the catalytic activity 
associated with wild-type PKD1 and PKD3 proteins were absent in these constructs as a 
result of point mutations of selected amino acids known to be essential for kinase activity.  
4.4.2 Baculovirus (II) 
In order to tranduct human neuroblastoma IMR32 cells, we designed baculovirus 
constructs to drive the expression of EGFP, OX1R, and truncated forms of trp channels 
(trpc3N and trpc6DN). All these recombinant baculoviruses were obtained using the Bac-
to-Bac expression system (Invitrogen). 
 
EGFP 
An AseI (blunted)–NotI fragment from pEGFP–N1 (BD Biosciences Clontech), including 
the cytomegalovirus (CMV) promoter and the gene for GFP, was subcloned into a SnaBI–
NotI gap in pFastBac1 (Invitrogen), removing the polyhedrin promoter. The resultant 
vector was called pFastBac–CMV–GFP. 
 
OX1R 
The OX1R cDNA (in pcDNA3, gift from M. Detheux) was processed by PCR to remove 
the stop codon and subsequently subcloned into pEGFP–N3 (BD Biosciences Clontech). 
The OX1R cDNA fused to the cDNA for GFP was then transferred to pFastBac–CMV–GFP 
as an EcoRI–NotI fragment. An untagged OX1R construct was generated by subcloning 
the whole coding sequence of OX1R cDNA into pFastBac–CMV–GFP, the GFP from 
vector being cut out. For plasma membrane localization of the red fluorescent protein 
(RFP) Discosoma red (DsRed)-Monomer, a CAAX motif from K-ras, KKKKKSKTKCVIM, 
was added to the EcoRI–BamHI gap of pDsRed-Monomer-C1 (BD Biosciences Clontech) 
by ligation of two complementary oligonucleotides, and subsequently the RFP fused to 
CAAX was transferred to pFastBac–CMV–GFP (GFP cut out) with BshTI and SphI.  
 
Trpc3N 
Trpc3N was constructed as described above and transferred to pFastBac-CMV–GFP, and 
the GFP cDNA was replaced by complementary oligonucleotides encoding a V5 epitope, 
followed by a STOP codon. 
 
Trpc6DN  
The htrpc6DN fused to YFP in pcDNA3 (gift from T. Gudermann) (Hofmann et al., 2002) 
was subcloned into pFastBac–CMV–GFP with BamHI and XbaI (GFP removed). 
4.4.3 Transfection Procedure (I, III, IV) 
CHO-hOX1-C1 and HEK293OX1R cells were transfected by using FuGENE 6 (Roche 
Applied Science) according to the manufacturer’s recommendations 18 – 24 hours after 
plating the cells on Petri dishes (35 mm inner diameter). One g of DNA and 3 l or 6 l 
of FuGENE 6 were used for CHO-hOX1-C1 and HEK293OX1R cells, respectively. The cells 
were used in experiments after 24 – 48 h of transfection. Stable transfection of 
HEK293OX1R cells by EGFP-PKD3 was achieved by transfecting the cells by the 
conventional procedure and by selecting the transfected cells with 400 g/ml geneticin.  
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4.4.4 Transduction Procedure (II) 
IMR32 cells were transduced by using recombinant baculoviruses. 0.5 ml of a high titer 
virus stock (107 pfu/ml), originating from Spodoptera frugiperda (Sf9) cell (Massotte, 2003; 
Aloia et al., 2009) infection, was spun down in a microcentrifuge at 12 000 rpm for 30 min. 
The pelleted viruses were resuspended in IMR32 cell culture medium, added to Petri 
dishes (35 mm inner diameter) with cells, and incubated until experimental use.  
4.5 CALCIUM IMAGING AND PATCH CLAMP RECORDINGS   
4.5.1 Media (I-IV) 
The HEPES-buffered Na+ based medium (HBM) consisted of 137 mM NaCl, 5 mM KCl, 1 
mM CaCl2, 0.44 mM KH2PO4, 4.2 mM NaHCO3, 10 mM glucose, 1 mM p-
[dipropylsulfamoyl]benzoic acid (probenecid, Sigma-Aldrich), 20 mM HEPES, and 1.2 
MgCl2. The pH was adjusted to 7.4 with NaOH. For experiments with IMR32 cells (II) 
and for electrophysiology (I), probenecid and MgCl2 were usually omitted, respectively. 
Ca2+ free medium was obtained by omitting CaCl2. The tetraethylammonium (TEA) and 
K+ based media were prepared by replacing Na+ with TEA or K+, respectively and by 
mixing this medium with the conventional one in order to achieve the desired TEA/K+ 
concentration.  
In electrophysiological experiments (I), the intracellular electrode solution used in the 
whole-cell voltage clamp recordings consisted of 136 mM Cs+ aspartate, 30 mM HEPES, 
10 mM NaCl, 4 mM ATP (Mg2+ salt, Sigma-Aldrich), and 0.6 mM GTP (Na+ salt, Sigma-
Aldrich). In current clamp recordings, Cs+ aspartate was replaced by K+ aspartate. The 
Ca2+ concentration was measured by using fura-2, pentapotassium salt (Molecular Probes) 
and adjusted to approximately 140 nM by adding 50 M ethylene glycol tetraacetic acid 
(EGTA, Sigma-Aldrich) and 25 M fura-2-acetoxymethyl ester (fura-2AM, Molecular 
Probes/Invitrogen). The effect of a high intracellular Ca2+ buffer capacity was tested in 
some 4 and 1 mM, respectively, or to 10 and 2.8 mM, respectively. The pH was adjusted 
to experiments by increasing the concentrations of EGTA and Ca2+ to 7.25 with CsOH or 
KOH. 
4.5.2 Preparation of the Cells  
For the Ca2+ imaging measurements in cell suspension, the cells (CHO-hOX1-C1 (I) and 
HEK293OX1R (III, IV)) were grown in 800 ml cell culture flasks in order to obtain a large 
quantity of cells. Near confluent cultures were grown, the cells were detached by 
standard protocol and spun down (1000 rpm, 3 min). The cell pellet was resuspended to 
pre-warmed HBM and loaded with fluorescent Ca2+ indicator fura-2AM (4 M) 
(Grynkiewicz et al., 1985) for 20 – 30 min at 37 °C. The cells were washed once with Ca2+-
free HBM and divided into aliquots. CHO-hOX1-C1 cells were stored on ice as pellets 
without medium and HEK293OX1R at room temperature as cell suspensions.  
For single cell Ca2+ imaging experiments (I-IV), the cells were plated on Petri dishes (35 
mm inner diameter) containing circular glass coverslips (25 mm inner diameter) in 2 ml 
of medium. The cell densities varied according to cell line and the particular experiment 
protocol which was being used. The density of 125 000 cells per plate was used for CHO-
hOX1-C1 (I). 250 000 HEK293OX1R cells (III, IV) were added per plate in other than 
oscillation experiments, in which the density of 400 000 cells per plate was used in order 
to obtain confluent monolayer of the cells, which is required for Ox-A induced Ca2+ 
oscillations to occur. In the case of IMR32 cells (II), confluent monolayer of cells from a 
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260 ml culture bottle were divided 1:3 or 1:4 and plated on dishes. In order to trigger 
differentiation in IMR32 cells, 5 M 5-bromo-2’-deoxyuridine (BrdU, Sigma-Aldrich) was 
added on the day after seeding. Thereafter, the medium was exchanged to fresh one 
containing BrdU every second or third day. Before the measurements of any above 
mentioned cell lines, the medium was exchanged to HBM and the cells were loaded with 
4 M fura-2AM for 20 - 30 min at 37 °C.   
In the electrophysiological studies (I), the cells were harvested from 260 ml cell culture 
bottles and plated on Petri dishes (35 mm inner diameter) containing square glass 
coverslips (22 x 22 mm) to a confluency of approximately 50 – 70 % on the day of use. 
After 3 h, the medium was exchanged to HBM and the cells were loaded with 2 M fura-
2AM for 20 min at 37 °C.   
4.5.3 Calcium Measurements in Cell Suspension  
One pellet of CHO-hOX1-C1 (I) or HEK293OX1R cells (III, IV) was resuspended in HBM 
at 37 °C and placed in a stirred quartz microcuvette in a thermostated cell-holder within a 
PTI QuantaMasterTM fluorescence spectrophotometer. Fluorescence was monitored at the 
wavelengths 340/380 (excitation) and 505 nm (emission). The experiments were calibrated 
by using 60 g/ml digitonin, which gives the maximum value of fluorescence, and 10 mM 
EGTA, which gives the minimum value of fluorescence.  
4.5.4 Single Cell Calcium Imaging Experiments  
The Ca2+ imaging experiments (I-IV) were performed and the data were analyzed by 
using the intracellular imaging InCyt2TM fluorescence imaging system (Intracellular 
Imaging). The cells were perfused with HBM at 37 °C and excited by alternating 
wavelengths of 340 and 380 nm by using narrow band excitation filters. The emitted 
fluorescence was measured through a 430 nm dichroic mirror and a 510 nm barrier filter 
with a Cohu CCD camera. One ratio image was acquired per second. Fluorescence from 
340 and 380 nm exposures were imported into Microcal OriginTM 6.0, and the ratios 
(340/380) were calculated. The cells over-expressing EGFP-tagged constructs were 
identified by EGFP fluorescence with 450 – 480 nm ultraviolet light.  
CHO-K1 cells have been shown previously to respond to 2’,3’-O-(4-benzoyl-benzoyl)-
ATP (BzATP) via activation of purinergic P2X (P2Z/P2X7) receptors (Michel et al., 1998). In 
our setup, the response of BzATP was not affected by transfection. Therefore, CHO-
hOX1-C1 cells were stimulated with 100 M BzATP (Sigma-Aldrich) at the end of each 
experiment and used the response as a control to cancel day to day variance (I). The 
responses evoked by Ox-A in individual cells were normalized with the response of 
BzATP. Oxotremorine (Research Biochemicals International), an agonist of muscarinic 
receptors, was used in IMR32 cells (II) to study the effect of TRPC6DN on Ca2+ response 
induced by GPCR other than OX1R. In HEK293OX1R cells (III, IV), which did not respond 
to BzATP, the responses evoked by 1 nM Ox-A concentration were normalized against 
those obtained with 100 nM Ox-A, which was unaffected by transfection.  
4.5.5 Patch Clamp Recordings (I)  
Ca2+ currents were measured in voltage clamp mode at 28 °C by using the standard 
whole-cell configuration (Hamill et al., 1981) while at the same time monitoring the [Ca2+]i 
by fura-2AM technique. The [Ca2+]i in cells in the vicinity of the patched cell was 
monitored as controls. The coverslip with the cells was attached to the bottom of an RC-
24 fast exchange chamber (Warner Instruments Inc.) and positioned on top of the 
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microscope. Cells were perfused with HBM by a gravity-controlled drug delivery system. 
The perfusates were converging in a perfusion manifold and funneled through an SH-
27B in-line heater (Warner Instruments Inc.) located just before the chamber inlet to 
obtain the desired temperature. Patch pipettes (model PG150T, Harvard Apparatus) were 
prepared with a PC-10 puller and flame-polished in a microforge MF-900 (Narishige) to a 
resistance of 3.6 – 3.8 megaohms measured in the bath solution. The patch clamp 
amplifier Axopatch 200A was connected to a computer via the AD/DA Digidata 1320E 
SCSI interface (Axon Instruments). Voltage protocols and data acquisition were 
controlled with pClamp 8.1 (Axon Instruments). Cells were compensated for the pipette 
capacitance, whereas following whole-cell access, the series resistance was analogically 
compensated to 60 – 70 %. Liquid junction potential was calculated using pClamp8.1 and 
subtracted from the recordings giving a more accurate clamping potential of 
approximately 60 mV. In general, voltage ramps (-80 to +80 mV; 320 ms) were applied 
every 5 or 7.5 s. Data were digitally sampled at 3.8 kHz and filtered at 2 kHz by using the 
low pass Bessel filter on the recording amplifier. In current clamp experiments, data were 
digitally sampled at 5 kHz and filtered at 2 kHz. Combined fluorescence recordings were 
obtained with a second computer running the TILLvisION Multi-Color Ratio 
ImagingSystem (TILL Photonics GmbH), and saved for later analysis. The system 
consisted of a polychrome IV and a 12-bit IMAGO CCD camera under the control of an 
external control unit. An inverted microscope (Nikon) was used to visualize the 
fluorescence. Ultraviolet light was guided through an epifluorescence condenser, and 
cells were excited through a dichroic mirror (DM430, Nikon). The emission was 
measured through a 510 nm cut-off filter (Nikon). The imaging protocol was designed to 
acquire images at 340 and 380 nm every 1–3 s. A transistor-transistor logic (TTL) trigger 
pulse synchronized the patch clamp and imaging recordings; the TTL pulse was 
controlled by TILLvisION 4.0 to trigger the voltage clamp data acquisition by using the 
“digitizer start input” option in the pClamp 8.1. After ending the recordings, fluorescence 
from 340 and 380 nm of selected regions of interest was analyzed and converted into 
[Ca2+]i as described previously (Lund et al., 2000). Voltage clamp and image data were 
then combined in Microcal OriginTM 6.0 for visualization and final analysis. 
4.5.6 Test Reagents (I-IV) 
Various test reagents used in Ca2+ imaging and patch clamp recordings and their most 
probable modes of action are listed in Table 6. 
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Table 6. Test reagents used in Ca2+ imaging and Patch clamp recordings  
Reagent, 
abbreviation 
Manufacturer Mode of action 
2-Aminoethoxydiphenyl borate,  
2-APB (I, III) 
Calbiochem Antagonist of IP3Rs and inhibitor of CCE 
Arachidonic acid, AA (III) Sigma-Aldrich Product of PLA2 action 
2’,3’-O-(4-benzoyl-benzoyl)-ATP, 
BzATP (I) 
Sigma-Aldrich Agonist of purinergic P2X (P2Z/P2X7) 
receptors 
R59022, DAGKI (I) Calbiochem Inhibitor of DAG kinase 
Dextromethorphan, Dex (I, II) Sigma-Aldrich Blocker of NMDA receptor channels and 
VOCs 
Digitonin (I, III, IV) Merck (I), Sigma-
Aldrich (III, IV) 
Solubilizer of plasma membranes 
Dioctanoyl glycerol, DOG (I, II) Sigma-Aldrich Analog of DAG, activator of PKC 
Ethylene glycol tetraacetic acid, 
EGTA (I, III, IV) 
Sigma-Aldrich Chelator of Ca2+ 
GF109203X, GF-X (I, II) Calbiochem Inhibitor of PKC 
Potassium chloride, KCl (I, II) Sigma-Aldrich Depolarizor of plasma membrane 
KB-R7943, KB-R (II) Tocris Cookson Blocker of the reverse operation mode of 
NCX 
Methyl arachidonyl 
fluorophosphate, MAFP (III) 
Cayman Chemical Inhibitor of PLA2 
Magnesium chloride, 
MgCl2 (I-III) 
Sigma-Aldrich Blocker of Ca2+ channels 
Nickel chloride, NiCl2 (I) Sigma-Aldrich Blocker of Ca
2+ channels 
-conotoxin (II) Tocris Cookson Blocker of N-type VOCs 
Orexin-A, Ox-A (I-IV) Bachem Agonist of OX1R 
Oxotremorine (II) RBI Agonist of muscarinic receptors 
SKF-96365, SKF (I) Calbiochem Inhibitor of CCE 
Tetraethylammonium, TEA (I) Sigma-Aldrich Blocker of K+ channels 
Thapsigargin (I, II) RBI Inhibitor of ER Ca2+-ATPase 
12-O-tetradecanoylphorbol-13-
acetate, TPA (I, II) 
Sigma-Aldrich Activator of PKC 
Abbreviations used: CCE = capacitative Ca2+ entry, DAG = diacylglycerol, ER = endoplasmic 
reticulum, IP3R = inositol 1,4,5-trisphosphate receptor, NCX = Na
+/Ca2+ exchanger, NMDA = 
N-methyl-D-aspartate, OX1R = orexin-1 receptor, PKC = protein kinase C, PLA2 = 
phospholipase A2, RBI = Research Biochemicals International, VOC = voltage-gated Ca
2+ 
channel. 
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4.5.7 Statistics (I-IV) 
Ratios of fluorescence from 340 nm and 380 nm exposures (ratio 340/380) were calculated 
with Microcal Origin 6.0. Absolute levels of [Ca2+]i and changes in Ca2+ levels (Δ*Ca2+]i) 
were obtained utilizing standard curve determined with known Ca2+ concentrations. The 
differences between two groups were evaluated by the unpaired Student’s t-test. One-
way ANOVA test followed by Scheffe’s test was used to determine the differences 
between more than two groups. p-values < 0.05 were considered as statistically 
significant.  
4.6 SUBCELLULAR FRACTIONATION (IV)  
HEK293OX1R cells or HEK293OX1R-EGFP-PKD3 cells were grown to near confluency on 
Petri dishes (10 mm inner diameter) in 8 ml of medium and treated with 1 nM or 50 nM 
Ox-A in HBM for 5 min. Cytosolic and membrane fractions were isolated according to 
Brott et al. (1998).  
4.7 IMMUNOLOGICAL ASSAYS (IV)   
4.7.1 Immunoblotting  
In order to detect protein kinases activated by Ox-A, specific antibodies were used: anti-
active ERK1/2 (Promega), anti-PKD1S916p (Cell Signalling), anti-PKC T505p (Cell 
Signalling), anti-PKC / T638/641p (Cell Signalling). Anti-actin (Sigma-Aldrich) was used 
as a loading control. HEK293OX1R cells were grown to near confluency on Petri dishes 
(35 mm inner diameter) in 2 ml of medium. The medium was exchanged to HBM and the 
cells were treated with 5 nM Ox-A at 37°C. HBM was removed, dishes were transferred 
on ice and cells were lyzed in a Radio-Immunoprecipitation Assay (RIPA) buffer (50 mM 
Tris, 150 mM NaCl, 1 % Triton X-100, 10 nM sodium fluoride (NaF), 100 M 
orthovanadate). The lysates were used in western blotting. 5 - 10 g of protein were run 
on 7.5 or 10 % acrylamide gel, transferred to polyvinylidene fluoride membrane and 
probed with antibodies according to the manufacturer’s instructions. Positive bands were 
detected with ECL+ (Enhanced Chemiluminescence) Western Blotting Detection Reagents 
(GE Healthcare) and scanned on STORMTM imaging system (GE Healthcare). The same 
western blot protocol was used to detect active PKD1 and PKD3 after subcellular 
fractionation described in section 4.6. Anti-EGFP (Clontech) followed by anti-active PKD 
(744/748) (Cell Signalling) was used in the case of PKD3 and anti-PKD1S916p (Cell 
Signalling) in the case of PKD1. Anti-OX1R (Alpha Diagnostics) was used as a loading 
control.  
4.7.2 Immunoprecipitation of Protein Kinase D3  
HEK293OX1R-EGFP-PKD3 cells were seeded on Petri dishes (60 mm inner diameter). 
When the cultures were nearly confluent medium was exchanged to HBM and the cells 
were treated with 1 and 50 nM Ox-A for 5 min. Cells were lyzed in RIPA buffer and the 
lysate was precleared with Dynabeads® Protein G (Invitrogen) for 1 h at 4 °C. The beads 
used in preclearing were replaced with the beads cross-linked to anti-EGFP polyclonal 
antibody (Clontech). The mixture was incubated at 4 °C over night with constant turning. 
The beads were then captured, washed three times with phosphate buffered saline (137 
mM NaCl, 2,7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7,2) and eluted in sample 
45 
 
buffer (62,5 mM Tris-HCl (pH 6,8), 25 % glycerol, 2 % sodium dodecyl sulphate, 0,01 % 
bromophenol blue, 5 % -mercaptoethanol). The eluates were used in western blotting as 
described above in chapter 4.7.1 (8 % acrylamide gel). Anti-active PKD (744/748) (Cell 
Signalling) was used to detect active PKD3.  
4.8 EPIFLUORESCENCE MICROSCOPY OF HEK293OX1R-EGFP-PKD3 
CELLS (IV) 
HEKOX1R-EGFP-PKD3 cells were plated on 12-well plates containing circular glass 
coverslips (0.9 mm inner diameter) in 1 ml of medium. At near confluency, medium was 
replaced with HBM with 1 or 50 nM Ox-A. At selected times (5 and 30 min), cells were 
fixed in formalin and fluorescent cells were observed with Olympus IX71 epi-
fluorescence microscope, Olympus IX71. Images were captured using Olympus DP 
controller software. 
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5 Results  
5.1 CELLULAR RESPONSES TO OREXIN-A 
5.1.1 Membrane Depolarisation  
Orexin peptides are known to be excitatory and the excitation of the target neurons can 
often be observed via membrane depolarization (rewieved in Kukkonen et al., 2002; 
Ferguson and Samson, 2003). The present whole-cell current clamp recordings with an 
intracellular K+-based solution revealed that 0.3 nM Ox-A evoked a highly voltage-
dependent depolarization of CHO-hOX1-C1 cell membrane (I, Fig. 5C and 5D). 
5.1.2 Elevation of Intracellular Calcium Concentration  
Dose-dependent transient increase in [Ca2+]i is a well characterized cellular response to 
stimulation of orexin receptors in both recombinant cell models and native systems 
(reviewed in Kukkonen et al., 2002). Ox-A induced Ca2+ responses were observed and 
characterized in all 3 recombinant cell models used in this study: CHO-hOX1-C1 cells, 
IMR32 cells transiently transduced by OX1R and HEK293OX1R cells. In these cell lines, 3 
nM or higher concentrations of Ox-A induced a two-phase Ca2+ response, consisting of a 
sharp peak and a delayed stable phase (see for example I, Fig. 1B, 2D and 2E, II, Fig. 1E 
and III, Fig. 1B, gray trace). Lower concentrations of Ox-A induced different Ca2+ 
responses in different cell lines: 1) In CHO-hOX1-C1 cells, a transient elevation of [Ca2+]i 
was observed, 2) in IMR32 cells, 1 nM Ox-A resulted in a stable elevation of [Ca2+]i (II, Fig. 
2A), which lasted for over 10 min and 3) in HEK293OX1R cells, prolonged stimulation 
with a low concentration of Ox-A resulted in repetitive spike patterns of [Ca2+]i known as 
Ca2+ oscillations, the frequencies of which were about 7 mHz (III, Fig. 1A). A similar 
oscillation pattern was also seen when HEK293OX1R cells were stimulated with a high 
concentration (100 nM) of Ox-A in the absence of extracellular Ca2+ (III, Fig. 1B). 
5.1.3 Increase of the Ion Current across the Membrane  
In CHO-hOX1-C1 cells, combined whole-cell voltage clamp and Ca2+ imaging recordings 
were undertaken in order to dissect Ox-A activated membrane current. A large 
proportion (about 45 %) of the patched cells responded to Ox-A stimulation with an 
increase in inward current and Ca2+ elevation (I, Fig. 4A), when the intracellular Ca2+ was 
buffered to a resting level similar to that in the intact cells. 
5.1.4 Activation of Protein Kinases   
Previously orexins have been demonstrated to activate several types of protein kinases 
(Kukkonen et al., 2002; Milasta et al., 2005; Ammoun et al., 2006a; 2006b; Ekholm et al., 
2007; Tang et al., 2008; Goncz et al., 2008; Ramanjaneya et al., 2009). In order to identify 
Ox-A activated protein kinases in HEK293OX1R cells, it was decided to treat near-
confluent cells with 5 nM Ox-A and lyse them at different time points in RIPA buffer. 
Total protein lysates were tested by western blotting being achieved with antibodies 
against phosphorylated forms of various protein kinases. It was found that the levels of 
phosphorylated forms of ERK1/2, PKC  and PKD1 were increased in a time-dependent 
manner in Ox-A treated samples compared to untreated controls (IV, Fig. 1A and B). This 
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study was the first one to identify PKD1 as a downstream target of OX1R. This finding led 
us to explore if other types of PKDs were expressed and activated by Ox-A in this cell 
model. Expression of all three subtypes of PKDs in HEK293OX1R cells was confirmed by 
reverse transcriptase PCR (RT-PCR) with sub-type specific primers (confirmed by 
sequencing). There is no subtype specific antibody for PKD3 but phosphorylation of all 
three PKD subtypes can be detected using an antibody against phosphorylated serine 
residue 744/748 in the active loop (Rykx et al., 2003). To test if PKD3 was specifically 
activated by Ox-A, HEK293OX1R cells were stably transfected with an EGFP-tagged 
PKD3 construct (Rey et al., 2006a). Immunoprecipitation with anti-GFP antibody of 
control and Ox-A treated cells and subsequent western blot detection with anti-active 
PKD(744/748) revealed increased phosphorylation of PKD3 after stimulating 
HEK293OX1R cells with 1 nM Ox-A for 5 min (IV, Fig. 4A).  
5.2 CHARACTERIZATION OF OREXIN-A INDUCED ELEVATION OF 
INTRACELLULAR CALCIUM CONCENTRATION AND MEMBRANE 
CURRENT 
5.2.1 Dependence on Extracellular Calcium  
In order to distinguish if Ca2+ was derived from the intracellular stores or from the 
extracellular space, the dependence of Ox-A induced Ca2+ responses on [Ca2+]o was tested. 
In the absence of extracellular Ca2+, Ca2+ influx from the extracellular space is prevented 
and only the release of Ca2+ from the intracellular stores can be seen. For example when 
CHO-hOX1-C1 cells were treated with 100 nM thapsigargin, an inhibitor of ER Ca2+-
ATPase causing discharge of the intracellular Ca2+ stores (Thastrup et al., 1990), only a 
peak response was observed (I, Fig. 1C). In the presence of extracellular Ca2+, this was 
followed by a delayed stable phase corresponding to CCE activated by store depletion (I, 
Fig. 1C). In all tested cell lines, the Ca2+ response to 3 nM or higher concentration of Ox-A 
had the same characteristics as that obtained with thapsigargin. In the presence of 
extracellular Ca2+, a two-phase response was observed while in the absence of 
extracellular Ca2+, only the peak response remained (see for example I, Fig. 1B, 2D and 2E, 
II, Fig. 1E and III, Fig. 1B, gray trace). However, Ca2+ responses induced by lower (≤ 3 nM) 
concentrations of Ox-A were acutely dependent on [Ca2+]o. No response was detected 
when the cells were stimulated in the absence of extracellular Ca2+ (see for example II, Fig. 
1D and F and III, Fig. 2B). In IMR32 cells transiently expressing OX1R, the dependence on 
extracellular Ca2+ was also evident if extracellular Ca2+ was removed during the stable 
elevation of [Ca2+]i. Under these conditions, the response was readily and reversibly 
blocked (II, Fig. 2b). In addition, the Ca2+ oscillations induced by 1 nM Ox-A in 
HEK293OX1R cells were reversibly blocked by removal of Ca2+ from the perfusion 
solution (III, Fig. 1A). Figure 8 summarizes the effect of [Ca2+]o on Ca2+ responses induced 
by Ox-A.  
Similarly as the Ca2+ response, also the membrane current evoked by 0.3 nM Ox-A was 
dependent on extracellular Ca2+ (I, Fig. 4A). Interestingly, the concentration-response 
relations of Ox-A induced membrane current and Ca2+ elevation differed significantly. 
The measured membrane current increased steeply from 0.1 to 0.3 nM Ox-A, after which 
no further increase in the magnitude of current could be evoked, even if the Ca2+ 
elevation continued to rise with increasing Ox-A concentrations (I, Fig. 4B).  
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Figure 8. Representative single cell calcium (Ca2+) imaging recordings showing the effect of 
extracellular Ca2+ on Ca2+ responses elicited by high (100 nM) and low (1 nM) concentrations 
of orexin-A (Ox-A). Periods of stimulation are indicated by horizontal bars. When a cell 
expressing orexin-1 receptor is stimulated by 100 nM Ox-A in the absence of extracellular 
Ca2+, only a transient elevation of intracellular Ca2+ concentration ([Ca2+]i) is observed (A). In 
the presence of extracellular Ca2+, 100 nM Ox-A induced a biphasic Ca2+ response (B). No 
response is detected when 1 nM Ox-A is used in the absence of extracellular Ca2+ (C), but in 
the presence of extracellular Ca2+, a short pulse of 1 nM Ox-A induces transient elevation of 
[Ca2+]i (D) and a longer stimulation results in a repetitive
 spike pattern known as Ca2+ 
oscillations (E). The oscillations cease if Ca2+ is removed from the perfusion solution. 
5.2.2 Sensitivity to Pharmacological Methods to Block Calcium Entry Pathways   
To confirm the necessity of Ca2+ entry from the extracellular space for the Ca2+ responses 
induced by low concentrations of Ox-A, a panel of pharmacological inhibitors known to 
block Ca2+ entry pathways were examined. The effects seen with the inhibitors were not 
due to changes in resting membrane potential as these compounds caused no or only 
marginal changes in our current clamp recordings in CHO-hOX1-C1 cells. Next the effects 
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of individual test reagents are described. The main findings are then summarized in 
Table 7. 
 
Magnesium (Mg
2+
) 
Mg2+ (5 mM), a nonselective Ca2+ channel blocker, dramatically reduced (by about 70 %) 
the Ca2+ elevation (I, Fig. 1A and 1E) and membrane current (I, Fig. 4C) induced by 0.3 
nM Ox-A in CHO-hOX1-C1 cells. When IMR32 cells transiently expressing OX1R were 
stimulated with 1 nM Ox-A in the presence of 10 mM Mg2+, only a small and transient 
Ca2+ response was observed instead of a prolonged stable elevation of [Ca2+]i (II, Fig. 2b). 
Furthermore, 10 mM Mg2+ reversibly blocked the sustained Ca2+ elevation when applied 
during the stimulation with 1 nM Ox-A (II, Fig. 2B and 2C). The same inhibitory effect of 
a high concentration of Mg2+ was seen also in HEK293OX1R cells: 10 mM Mg2+ reversibly 
blocked the Ca2+ oscillations induced by 1 nM Ox-A, decreasing the oscillation frequency 
by 87 % (III, Fig. 3A and 3E). Mg2+ treatment did not have any visible effect on the Ca2+ 
responses (peak responses or Ca2+ oscillations seen in the absence of extracellular Ca2+) 
induced by higher concentrations of Ox-A (≥ 3 nM) or by thapsigargin in any of the tested 
cell lines (I, Fig. 1C and 1E, II, Fig. 4A, III, Fig. 3B and 3E).  
 
Tetraethylammonium (TEA) 
In CHO-hOX1-C1 cells, 70 mM TEA, a nonspecific potassium channel blocker, had an 
effect which was very similar to that seen with Mg2+, clearly inhibiting the Ca2+ response 
induced by a low concentration of Ox-A, but having no significant effect on responses at 
higher concentrations of Ox-A (I, Fig. 1E). In patch clamp recordings, 70 mM TEA totally 
and reversibly blocked the membrane current induced by 0.3 nM Ox-A while not 
interfering with the basal current (I, Fig. 4F).  
 
Dextromethorphan (Dex) 
Dex was originally identified as a -opiate receptor ligand but was subsequently shown 
to reversibly block NMDA receptor channels and VOCs (Albers et al., 1989; Church and 
Fletcher, 1995; Shariatmadari et al., 2001). In CHO-hOX1-C1 cells, it had a comparable 
inhibitory profile as Mg2+ and TEA. A concentration of 100 M Dex totally inhibited Ca2+ 
elevation (I, Fig. 1A and 1E) and the membrane current (I, Fig. 4E) induced by a low 
concentration of Ox-A, but had no effect on peak response of higher Ox-A concentrations 
or thapsigargin (I, Fig. 1B, 1C and 1E). However, stable phases occurring after peak 
responses and the corresponding CCE activated by store release were partially inhibited 
by Dex (I, Fig. 1B, 1C and 1E). Similar effects of Dex were seen in IMR32 transiently 
expressing OX1R. Dex almost completely blocked the sustained response to 1 nM Ox-A in 
IMR-32 cells (II, Fig. 2B and 2C), but had only a small inhibitory effect on the sustained 
elevation of [Ca2+]i induced by thapsigargin (II, Fig. 4A and 4B).  
 
SKF-96365 (SKF) 
In CHO-hOX1-C1 cells, 10 M SKF, a known inhibitor of CCE (Merritt et al., 1990), had 
only a minor inhibitory effect on the Ca2+ elevation at a low concentration of Ox-A, but 
partially inhibited the response induced by higher concentration of Ox-A (I, Fig. 1E). 
When applied during the stable phase of the thapsigargin induced Ca2+ response, SKF 
achieved total inhibition (I, Fig. 1E).  
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2-Aminoethoxydiphenyl borate (2-APB) 
In CHO-hOX1-C1 cells, 10 M 2-APB, an antagonist of IP3Rs and an inhibitor of CCE 
(Wilcox et al., 1998), was able to reverse the response to thapsigargin when added during 
the stable phase (I, Fig. 1B, 2-APB). It had no effect on the Ca2+ oscillations induced by 1 
nM Ox-A in HEK293OX1R cells (III, Fig.3C and 3E) but blocked the oscillations induced 
by 100 nM Ox-A in the absence of extracellular Ca2+, decreasing the oscillation frequency 
by 93 % (III, Fig. 3D and 3E).  
 
Table 7. Effect of various inhibitors on different aspects of Ca2+ responses: peak responses 
(peak), stable phases (stable), Ca2+ oscillations (osc) and membrane current (current) 
induced by different Ox-A concentrations or by thapsigargin (thaps). The number of minus 
signs indicates the magnitude of the inhibitory effect (- low level of inhibition, -- intermediate 
inhibition and --- very strong inhibition). NE indicates no or only marginal effect. 
Ox-A Mg2+ Dex TEA SKF 2-APB Ni2+ 
0.3 nM / 1 nM -- --- -- -   
1 nM (osc) ---    NE  
0.3 nM (current) - --- ---  NE --- 
10 nM (peak) NE NE NE -   
10 nM (stable) NE -- NE --   
100 nM (osc) NE    ---  
Thaps (peak) NE NE  -   
Thaps (stable) - -  --- ---  
Abbreviations used: 2-APB = 2-aminoethoxydiphenyl borate, Dex = dextromethorphan, Mg2+ 
= magnesium ion, Ni2+ = nickel ion, SKF = SKF-96365, TEA = tetraethylammonium. 
5.2.3 Dependence on Voltage   
The present patch clamp recordings in CHO-hOX1-C1 cells indicate that in addition to 
Ox-A induced membrane depolarization, also inward current and Ca2+ response are 
voltage-dependent. Using a voltage protocol introducing voltage ramps (-80 to +80 mV; 
320 ms) every 5 or 7.5 s, an approximately linear increase in the inward current with an 
increasing negative intracellular polarity was recorded (I, Fig. 5A and 5B). The Ca2+ 
response to 0.3 nM Ox-A was clearly reduced by substitution of extracellular Na+ with K+, 
which caused a considerable depolarization of the cells, while the same treatment had 
little effect on the peak elevation at 3 nM Ox-A (I, Fig. 5F and 5G). 
5.3 SIGNALLING PATHWAYS PARTICIPATING IN THE REGULATION OF 
THE OREXIN-A INDUCED ELEVATION OF THE INTRACELLULAR 
CALCIUM CONCENTRATION 
5.3.1 Protein Kinase C 
DAGs are produced following activation of various GPCRs by actions of PLC (reviewed 
in Rebecchi and Pentyala, 2000) or other phospholipases (Hodgkin et al., 1998; Wakelam, 
1998) with the main target of these second messengers being PKC. The effect of PKC 
stimulation and inhibition was evaluated on Ca2+ responses induced by low (0.3 nM) and 
high (10 nM) concentrations of Ox-A and 100 nM thapsigargin in cell suspensions of 
CHO-hOX1-C1. Different approaches used to activate PKC (30 M dioctanoyl glycerol 
(DOG), 100 nM 12-O-tetradecanoylphorbol-13-acetate (TPA), inhibition of DAG kinase by 
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30 M R59022) considerably lowered Ca2+ response induced by 0.3 nM Ox-A (I, Fig. 2A, 
2B, 3A, and 3C). DOG was without any effect on the Ca2+ responses induced by 10 nM 
Ox-A and 100 nM thapsigargin (both peak and stable phases) and consistently TPA did 
not significantly alter the response induced by 10 nM Ox-A (I, Fig. 2C, 2D, 2E, 3B, and 3C). 
PKC inhibition by 10 M GF109203X (GF-X) evoked a small increase in the response to 
0.3 nM Ox-A and almost completely reversed the inhibitory effects of DOG and R59022 (I, 
Fig. 3A). It did not prevent store release and the CCE caused by thapsigargin treatment (I, 
Fig. 3B). Very similar results were obtained in single cell Ca2+ imaging experiments of 
IMR32 cells. A concentration of 30 M DOG considerably decreased the elevation of 
[Ca2+]i induced by a low concentration of Ox-A and the response was restored or even 
enhanced by 10 M GF-X (II, Fig. 7A and 7B). When 100 nM TPA was applied during the 
the stable phase of Ca2+ response to 1 nM Ox-A, the level of [Ca2+]i was clearly lowered. 
This inhibition was partially reversed by GF-X treatment (II, Fig. 7C and 7D). The effect of 
GF-X was also tested in HEK293OX1R cells and it was found that the Ca2+ response to low 
concentration of Ox-A remained unaffected while GF-X decreased the responses to 10 nM 
and 100 nM Ox-A by over 40 % (IV, Fig. 3B). The main findings with PKC activators and 
inhibitor are also summarized in Table 8. 
 
Table 8. Effect of various activators and inhibitors of PKC on Ca2+ responses induced by 
different Ox-A concentrations or by thapsigargin (thaps). The number of minus signs indicates 
the magnitude of the inhibitory effect (- low level of inhibition, -- intermediate inhibition and -
-- very strong inhibition). + sign indicates enhancement of the response and NE no or only 
marginal effect. 
 0.3 nM / 
1 nM 
10 nM 
(peak) 
10 nM 
(stable) 
Thaps 
(peak) 
Thaps 
(stable) 
DOG --- NE NE NE NE 
TPA --- - -   
DAGKI --     
GF-X + -  NE NE 
DOG + GF-X NE / +     
TPA + GF-X -     
DAGKI + GF-X NE     
Abbreviations used: DAGKI = diacylglycerol kinase inhibitor R59022, DOG = dioctanoyl 
glycerol, GF-X = GF109203X, TPA = 12-O-tetradecanoylphorbol-13-acetate. 
5.3.2 Phospholipase A2 
OX1R is believed to activate multiple phospholipases (Johansson et al., 2008). It was 
decided to investigate the potential role of PLA2 in OX1R signalling in HEK293OX1R cells. 
Already a low concentration (1 nM) of Ox-A released a significant amount of AA, the 
main product of the activity of PLA2 (III, Fig. 2A). Methylarachidonyl fluorophosphonate 
(MAFP), an inhibitor of PLA2 (Lucas and Dennis, 2005), had a striking effect on Ox-A 
induced Ca2+ oscillations, decreasing the oscillation frequency by 76 % (III, Fig. 2B and 2E). 
Subsequent addition of AA rescued the Ca2+ elevation, but failed to rescue the oscillation 
pattern (III, Fig. 2C). The oscillatory responses induced by 100 nM Ox-A in the absence of 
extracellular Ca2+ were largely unaffected by MAFP (III, Fig. 2D). 
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5.3.3 Protein Kinase D1 and D3 
The recent identification of activation of PKD1 and PKD3 by OX1R stimulation was a 
reason to explore their possible roles in the regulation of Ox-A induced Ca2+ responses. 
First the responses of PKD1 and Ca2+ were compared. Ox-A induced phosphorylation of 
PKD1 at S916 and elevation of [Ca2+]i in HEK293OX1R cells were both very early 
responses detected at around 1 min after stimulation. A low concentration of Ox-A was 
sufficient to elicit these responses (IV, Fig.2A and 2B). The concentration-response 
relations of PKD1 S916 phosphorylation and [Ca2+]i elevation were superimposable (IV, 
Fig. 2C). Secondly, cell fractionation experiments and fluorescence microscopy pictures 
demonstrated a clear Ox-A induced translocation of both PKD1 and PKD3 on the plasma 
membrane indicative of an active role for these kinases in this cell compartment (IV, Fig. 
4B and 4C). Finally, in order to more directly test the effects of PKDs on Ox-A induced 
Ca2+ responses, HEK293OX1R cells were transfected with EGFP-tagged kinase-dead PKD1 
(PKD1kd) (Hausser et al., 2002) and EGFP-tagged kinase-dead PKD3 (PKD3kd) (Rey et 
al., 2006a) and single cell Ca2+ imaging experiments were conducted. Neither construct 
had any significant effect on peak amplitudes of Ca2+ responses induced by Ox-A 
(comparison of fluorescent cells expressing kinase-dead construct with non-fluorescent 
control cells on the same plate). However, the recorded oscillation patterns were 
considerably altered. Over-expression of PKD1kd increased the frequency of the 
oscillations by approximately 1 peak per every 10 min of stimulation (6.2 ± 0.4 mHz in 
PKD1kd expressing fluorescent cells (n = 62) versus 4.9 ± 0.3 mHz in control cells (n = 42), 
IV, Fig. 5A). The observed increase was statistically significant (IV, Fig. 5B). On the other 
hand, over-expression of PKD3kd in HEK293OX1R cells completely disrupted the 
oscillation pattern (IV, Fig. 6A) with only a sustained [Ca2+]i elevation remaining. The 
number of transiently oscillating cells was significantly decreased in this cell group 
compared to corresponding non-fluorescent control group (IV, Fig. 6B). 
5.4 IDENTIFICATION OF THE CHANNEL ISOFORMS INVOLVED IN THE 
CALCIUM INFLUX INDUCED BY A LOW CONCENTRATION OF OREXIN-A 
5.4.1 Voltage-gated Calcium Channels 
Orexins have been reported to depolarize cells via several different mechanisms 
(reviewed in Kukkonen et al., 2002; Ferguson and Samson, 2003). Thus it seemed 
profitable to investigate if Ox-A induced [Ca2+]i elevation was mediated via 
depolarization-activated VOCs in IMR32 cells. A high concentration of Mg2+, which is 
able to block Ox-A induced Ca2+ response (II, Fig. 2B-E), did not have any effect on 
depolarization-induced Ca2+ influx (II, Fig. 3A). Differentiation of IMR-32 cells leads to an 
upregulation of mainly N-type VOCs, which can be blocked with conotoxin (Carbone 
et al., 1990). Accordingly, the depolarization-induced Ca2+ influx was largely abolished by 
0.5 M conotoxin (II, Fig. 3A), but the same treatment had no effect on the Ox-A 
induced Ca2+ response (II, Fig. 3C and 3D). Furthermore, the OX1R response was still 
present and not apparently different from control in conotoxin-treated cells that also 
receivedexposure to a depolarizing buffer before and during Ox-A application (II, Fig. 
3C). 
5.4.2 Na+/Ca2+ Exchanger 
The electrogenic Na+/Ca2+ exchanger has been implicated in OxR-mediated neuronal 
excitation (Eriksson et al., 2001; Burdakov et al., 2003; Wu et al., 2004) and thus its 
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possible involvement in Ox-A induced Ca2+ influx was explored. KB-R7943 (KB-R), a 
potent blocker of the reverse operation mode of Na+/Ca2+ exchange (Iwamoto et al., 1996), 
did not significantly alter the response to Ox-A in IMR-32 cells when averages of cells 
were plotted and compared (II, Fig. 4C and 4D). However, when analyzed at the single-
cell level, the cells could be divided into three populations responding differentially: 1) 
about 10 % of the cells showed a decrease in [Ca2+]i when KB-R was applied during the 
stable phase of Ox-A induced Ca2+ response, 2) the response in about 75 % of the cells did 
not alter and 3) about 15 % of the cells showed an increase in [Ca2+]i in response to KB-R.  
5.4.3 Canonical Transient Receptor Potential Channels 
DAGs have been shown to activate some subtypes of TRP channels independently of 
receptor activation (Hofmann et al., 1999; Tesfai et al., 2001; Jung et al., 2002; Gamberucci 
et al., 2002). Evidence for DAG-activated Ca2+ entry in CHO-hOX1-C1 cells and in 
differentiated IMR32 cells was found. DOG (30 M), an analog of DAGs, caused an 
increase in [Ca2+]i in both cell lines (CHO-hOX1-C1: data not shown, IMR32: II, Fig. 6A 
and 6D). Further characterization of DOG-induced [Ca2+]i elevation was performed in 
IMR32 cells. In a similar manner as the Ox-A induced increase in [Ca2+]i, this response 
was sensitive to a high concentration of Mg2+ (II, Fig. 6B and 6D) and to Dex (II, Fig. 6C 
and 6D). The PKC inhibitor (GF-X) significantly enhanced the response to DOG (II, Fig. 
6D). Stimulation of the OX1R during DOG application caused only a small, additional 
elevation of [Ca2+]i (II, Fig. 7A and 7B) and, in a significant number of cells, no additional 
elevation at all.  
The possible role of DAG-activated TRPC channels in Ox-A induced Ca2+ influx 
naturally is dependent on the channels being expressed in the cells. Thus the presence of 
the mRNA for different channel subtypes was investigated in CHO-hOX1-C1 and 
differentiated IMR32 cells. The RT-PCR experiments confirmed the expression of mRNA 
for trpc1, trpc2, trpc3 and trpc4 in CHO-hOX1-C1 cells (I, Fig. 6) and for all human trpc-
type channels in differentiated IMR32 cells (II, Fig. 5). In addition, the third cell line used 
in this study, HEK293 cells, has been previously shown to express mRNA for several trpc 
subtypes (trpc1, trpc3, trpc4 and trpc6) (Garcia and Schilling, 1997; Wu et al., 2000). 
In order to more directly test the involvement of TRPC channels in Ox-A induced Ca2+ 
responses, EGFP/EYFP-tagged truncated TRPC channel subtypes were designed having 
dominant negative effects on channel activity. These constructs were transfected into the 
cells and single cell Ca2+ imaging experiments were conducted. Transfected cells 
expressing truncated TRPC constructs were easy to identify based on their fluorescence 
and thus the Ox-A induced Ca2+ responses of fluorescent cells and non-fluorescent control 
cells from the same plates were compared. In CHO-hOX1-C1 cells, expression of trpc1N 
or trpc3N significantly attenuated Ca2+ responses induced by 0.3 nM Ox-A (I, Fig. 7B) 
while responses to a higher (3 nM) concentration of Ox-A remained unaffected (I, Fig.7A 
and 7B). After normalization of the responses against that observed with 100 mM BzATP 
(see chapter 4.5.4 Single Cell Ca2+ Imaging Experiments for further information), 
significant inhibitory effects of trpc1N and trpc3N, minor effects of trpc2N and trpc4N 
and no effects of EGFP and trpc7N were noted on the Ca2+ responses induced by 0.3 nM 
Ox-A (I, Fig. 6B). Trpc1N and trpc3N also reduced the number of responding cells by 
21 % and 11 %, respectively. The effect of trpc1N and trpc3N was not due to their 
possible effect on membrane potential because transfected cells had similar resting 
potentials as their nontransfected counterparts.  
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In differentiated IMR32 cells, trpc3N had only a minor inhibitory effect on the Ca2+ 
response to 1 nM Ox-A. This was considered to be attributable to too low expression level 
or the inability of this truncated construct to interact sufficiently well with the 
endogenous related channel subunits. Therefore, a full-length, triple-mutated trpc6 
dominant-negative construct (trpc6DN) (Hofmann et al., 2002) was tested and this almost 
totally abolished the Ca2+ response induced by 60 M DOG (II, Fig. 8A, 8B and 8E) and 
significantly inhibited the response to 1 nM Ox-A. In contrast, the peak responses to 10 
nM Ox-A and to oxotremorine (an agonist of endogenous muscarinic receptors 
(Kukkonen et al., 1992) used to evaluate health and viability of the cells) remained 
unaltered (II, Fig. 8C, 8D and 8F).  
In similar experiments in HEK293OX1R cells, trpc1N, trpc3N and trpc4N decreased the 
Ca2+ response to 1 nM Ox-A leaving the response to 100 nM Ox-A unaffected. The 
response to 100 nM Ox-A was used to normalize the responses to low concentration of 
Ox-A and this procedure revealed significant inhibitory effects of the channel constructs 
described above and no effects of trpc6DN and trpc7N (III, Fig. 1C). The effect of truncated 
channel constructs was also tested on Ca2+ oscillations induced by prolonged stimulation 
of HEK293OX1R cells by 1 nM Ox-A. The cells over-expressing trpc3N failed to produce 
the transient Ca2+ oscillations characteristically seen in the non-transfected cells (III, Fig. 
1D). Statistical analysis established that expression of trpc3N significantly decreased the 
percentage of transiently oscillating cells as compared to the control cells (III, Fig. 1E).  
In order to compare the characteristics of the primary current response to Ox-A and 
the TRPC3 mediated current, CHO-hOX1-C1 cells were transfected with trpc3FLAG and 
fluorescent cells were clamped at -80 mV. Under these conditions, TRPC3 was 
constitutively active. In general, inward currents were transient and were followed by a 
more steady current level, ranging around -250 to -600 pA (I, Fig.8A) (Zitt et al., 1997). 
Inhibitors, which had been previously shown to block Ox-A induced current were 
applied during the more steady current level. Three compounds, i.e. 70 mM TEA, 5 mM 
Mg2+ and 100 M Dex, all blocked the TRPC3 current (I, Fig.8B). The magnitude of the 
block by TEA was on average found to be approximately 86 % with respect to zero 
current. Dex reduced the TRPC3 current by approximately 71 % and Mg2+ by 
approximately 50 %.  
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6 Discussion 
In line with numerous previous studies, it was confirmed that membrane depolarization, 
elevation of [Ca2+]i, an increase in the ion current across the plasma membrane, and 
activation of several protein kinases were the cellular responses induced by stimulation 
of OX1R by Ox-A. It was also possible to identify PKD1 and PKD3 as novel targets of 
OX1R mediated activation. The present study intended to characterize in detail the Ca2+ 
signalling pathways utilized by the receptor. Previous studies have implicated two 
separate pathways as being involved in the elevation of [Ca2+]i induced by Ox-A. 
Activation of PLC pathway leading to release of Ca2+ from the intracellular Ca2+ stores 
at high nanomolar concentrations of Ox-A is firmly established by previous studies 
(Smart et al.,  1999; Kukkonen and Akerman, 2001; Muroya et al., 2004; Ekholm et al., 
2007; Johansson et al., 2007; 2008) and confirmed by these present investigations. Thus it 
was decided to concentrate on studying the Ca2+ responses induced by lower and 
probably physiologically more relevant concentrations of Ox-A, which are believed to be 
generated by receptor-operated Ca2+ influx from the extracellular space without 
detectable discharge of Ca2+ stores (Lund et al., 2000; Ammoun et al., 2003; Magga et al.,  
2006; Ekholm et al., 2007).  
In addition to initial peak response in [Ca2+]i, Ca2+ oscillations were observed in two 
separate conditions: when HEK293OX1R cells were stimulated by low nanomolar 
concentration of Ox-A for a prolonged period of time and when OX1R was activated by 
higher concentration of Ox-A in the absence of extracellular Ca2+. Ca2+ oscillations are 
recognized to be an important phenomenon in almost all cell types (Tsien and Tsien, 1990; 
Berridge, 1995; Parkash and Asotra, 2010). Different cellular processes such as the 
activation of protein kinases and transcription factors are regulated by Ca2+ oscillations at 
defined frequencies in the range between 1 and 100 mHz (reviewed in Boulware and 
Marchant, 2008). The frequency of Ox-A induced Ca2+ oscillations was about 7 mHz, 
which is known to activate protein kinases like ERK1/2 and PKC. Interestingly Ox-A 
activates these kinase pathways in non-excitable cells and in neurons in a Ca2+ dependent 
manner (Ammoun et al., 2006a).  
6.1 LOW CONCENTRATION OF OREXIN-A ACTIVATES CALCIUM INFLUX 
PATHWAY DISTINCT FROM THE CAPACITATIVE CALCIUM ENTRY  
Multiple lines of evidence presented in this study are in accordance with the current 
model of Ca2+ signalling of OX1R. The Ca2+ responses (both transient and repetitive) at 
low concentrations of Ox-A were acutely dependent on [Ca2+]o while higher Ox-A 
concentrations induced elevation of [Ca2+]i also in the absence of extracellular Ca2+. In 
CHO-hOX1-C1 cells, the Ox-A-activated current and membrane depolarization showed a 
steep dependence on a negative membrane potential. Similarly, the Ca2+ responses 
induced by 0.3 nM Ox-A were voltage-dependent while the responses to higher 
concentrations of Ox-A were unaffected by depolarization with high K+. Transiently 
transduced IMR32 cells responded to 1 nM Ox-A with a robust elevation of [Ca2+]i in the 
absence of measurable Ca2+ release from intracellular stores. All these results indicate that 
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the Ca2+ influx from the extracellular space is the primary response to low concentration 
of Ox-A instead of Ca2+ release from the intracellular stores.   
As a first step to characterize this Ca2+ entry pathway, it was decided to explore if it 
was mediated via the same or different molecular entity as the CCE. It is difficult to 
conduct a pharmacological differentiation of non-store-operated channels from 
capacitative mechanisms due to the lack of specific blockers or other specific means to 
distinguish the pathways. Thus a panel of channel inhibitors was screened on the 
responses to Ox-A and thapsigargin, in order to identify compounds that would show a 
preference for blocking a putative non-capacitative Ca2+ entry over the typical CCE. From 
the results (see Table 7 in Results section), it is evident that the pharmacological profiles 
of the Ca2+ signalling pathways activated by low (0.3 nM or 1 nM) and high (10 nM or 100 
nM) concentrations of Ox-A are distinct, suggesting that there are two separate molecular 
entities in the two cases. The first pathway is inhibited by known channel blockers Mg2+, 
Dex, TEA and Ni2+ while the latter is mostly sensitive to inhibitors of CCE, SKF and 2-
APB. Similar effects of Ni2+ and 2-APB on Ox-A induced Ca2+ responses have already 
been reported (Kukkonen and Akerman, 2001; Holmqvist et al., 2002). It should also be 
noted that the results with high concentrations of Ox-A and with thapsigargin, which is 
known to induce discharge of intracellular Ca2+ stores and the subsequent CCE via 
inhibition of ER Ca2+-ATPase, are very similar providing further support for the concept 
of activation of PLC -pathway by high concentrations of Ox-A. These results are in line 
with the previous ones showing that SOCs are inhibited by SKF (Merritt et al., 1990) and 
by 2-APB (Wilcox et al., 1998; Kukkonen and Akerman, 2001), but not by Mg2+ (Voets et 
al., 2001).  
Interestingly, also the Ca2+ oscillations in HEK293OX1R cells shared the similar 
characteristics with the initial peak response observed in other types of cells. The Ca2+ 
influx pathway participating in the generation and maintenance of oscillatory response 
pattern has been often postulated to involve CCE via SOCs (Bootman et al., 1996; 
Sergeeva et al., 2000; Bird and Putney et al., 2005). However, these results with 1 nM Ox-
A appear to indicate the involvement of some non-capacitative Ca2+ entry channel which 
is sensitive to elevated Mg2+ concentrations and is unaffected by 2-APB. At higher 
concentration of Ox-A, Ca2+ oscillations are only seen in the absence of extracellular Ca2+ 
ruling out the possible role of any channel type. The response pattern is most probably 
generated by repetitive release and reuptake of Ca2+ from the intracellular stores 
(reviewed in Tsien and Tsien, 1990; Taylor and Thorn, 2001; Berridge, 2005). In the 
present experiments, 2-APB was able to inhibit this process and to totally abolish the 
responses.  
6.2 PROTEIN KINASE C, PHOSPHOLIPASE A2, PROTEIN KINASE D1, 
AND PROTEIN KINASE D3 PARTICIPATE IN THE REGULATION OF 
OREXIN-A INDUCED ELEVATION OF INTRACELLULAR CALCIUM 
CONCENTRATION 
6.2.1 Protein Kinase C 
Next it was intended to identify specific signalling molecules participating in the 
regulation of Ca2+ entry induced by low concentration of Ox-A in order to obtain more 
clues about which of the possible channels are involved. PKC has been shown to tightly 
associate to Ca2+ signalling of the cells and to regulate the function of multiple ion 
channels on the plasma membrane (Tornquist, 1993; Miyakawa et al., 1998; van Rossum 
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and Patterson, 2009). The effects of activation and inhibition of PKC subtypes were 
explored on Ca2+ responses induced by different concentrations of Ox-A or by 
thapsigargin. It is evident from these results (see Table 8 in Results section) that the Ca2+ 
signalling pathways activated by low and high concentrations of Ox-A are regulated 
differentially. Thus, these results are in agreement with the findings presented above and 
provide still further support to the separate signalling pathways activated depending on 
the concentration of the stimulating agonist. The elevation of [Ca2+]i induced by low 
nanomolar concentrations of Ox-A could be blocked in several ways which activate PKC 
(DOG, TPA and DAGKI) and enhanced by PKC inhibitor GF-X. Furthermore, GF-X was 
able to reverse the responses inhibited by DOG and DAGKI. It seems that PKC plays a 
pivotal role in the regulation of the Ca2+ influx pathway activated by Ox-A. One attractive 
explanation for the inhibitory effect of PKC is that PKC functions as a negative feedback 
to regulate Ca2+ influx in order to prevent massive elevation of [Ca2+]i which might be 
harmful for the cell (Venkatachalam et al., 2003; Trebak et al., 2003). PKC has been 
already earlier shown to inhibit Ca2+ entry in response to receptor stimulation (Tornquist, 
1993; Miyakawa et al., 1998). Several studies have identified PKC as a crucial 
intermediate effector of signalling pathways activated by orexins, often via a downstream 
effect linked to specific ion channels (Uramura et al., 2001; Xu et al., 2002: Kohlmeier et al., 
2004) or less well defined ion conductances (Yang et al., 2003). In addition, a 
contradictory result has been reported. In hypothalamic neurons, van den Pol et al. (1998) 
observed a total block of the Ox-A induced [Ca2+]i increase after inhibition of PKC.  
Ca2+ responses induced by higher concentration of Ox-A or by thapsigargin were 
largely unaffected by PKC activators and/or inhibitors. Furthermore, the Ca2+ signalling 
pathways of high concentrations of Ox-A and thapsigargin displayed similar 
characteristics. Previously it has been shown that the capacitative pathway (the stable 
phase of the Ca2+ response) is unaffected by PKC activation (Venkatachalam et al., 2003). 
However PKC might have a role in regulating the events preceding activation of CCE, i.e. 
the release of Ca2+ from the intracellular stores (van Rossum and Patterson, 2009). The 
inhibitory effect of GF-X on Ca2+ responses induced by 10 and 100 nM Ox-A in 
HEK293OX1R points to that direction. OX1R has multiple consensus sites for PKC 
phosphorylation (Kukkonen et al., 2002) and one could argue that the effect of PKC is a 
direct phosphorylation of the receptor. However these results are contradictory to this 
hypothesis since the effects of PKC differs depending on the concentration of the 
stimulating agonist. 
6.2.2 Phospholipase A2  
In addition to SOCs (Bootman et al., 1996; Sergeeva et al., 2000; Bird and Putney, 2005), a 
novel non-capacitative Ca2+ entry activated by AA (Akagi et al., 1997; Wu X. et al., 2002; 
Shuttleworth and Thompson, 1999) has been proposed to be responsible for the Ca2+ 
oscillations induced by GPCR stimulation. Thus it was decided to explore if AA 
participates in generation of oscillatory Ca2+ responses in HEK293OX1R cells stimulated 
by 1 nM Ox-A. This concentration of agonist was able to induce a considerable release of 
AA in the cells and increasing the dose further elevated the release. Inhibition of PLA2, 
the main source of AA in the cells (reviewed in Diaz and Arm, 2003; Hirabayashi et al., 
2004), by MAFP (Lucas and Dennis, 2005) potently inhibited the Ca2+ oscillations induced 
by 1 nM Ox-A, but left oscillations at higher Ox-A concentration mostly untouched. AA 
was able to rescue the Ca2+ response inhibited by MAFP. These results indicate that PLA2 
participates in the regulation of Ca2+ influx induced by low concentrations of Ox-A while 
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at higher concentrations PLC dominates. Although the involvement of AA-activated 
influx pathway in the oscillatory response of OX1R has been demonstrated, the 
involvement of an ARC as postulated by Shuttleworth et al. (2004) cannot be confirmed 
as other types of channels with distinct characteristics are also activated by AA (for 
review see for example van Rossum and Patterson, 2009).  
6.2.3 Protein Kinase D1 and D3 
It was found that ERK1/2, PKC  and PKD1 were rapidly phosphorylated after treatment 
of HEK293OX1R cells by Ox-A. The phosphorylation of ERK1/2 with the same 
characteristics as observed here have been reported previously by several research 
groups (Kukkonen et al., 2002; Milasta et al., 2005; Ammoun et al., 2006a; Ramanjaneya et 
al., 2009). As described above, PKC has been postulated to be of crucial importance in 
Ca2+ signalling of OX1R. However, the specific PKC subtypes have not been identified and 
there is also a possibility that the effects seen with various inhibitors and activators are 
indirect and mediated via some downstream targets of PKC. The activation of PKC  by 
Ox-A has been proposed earlier by Holmqvist et al. (2005) based on their 
pharmacological data and this present investigation confirmed the specific 
phosphorylation of this PKC subtype by Ox-A treatment. The phosphorylation of PKD1 
by Ox-A was a novel finding and lead to the exploration of how this protein kinase and 
other members of the same kinase family participate in OX1R signalling.  
All known members of PKD family, PKD1, 2 and 3, were expressed in HEK293OX1R 
cells and it was possible to demonstrate activation of PKD3 in the same conditions and at 
the same time as PKD1. Once activated, PKDs are usually translocated to specific cellular 
compartments: membrane (Matthews et al., 2000; Oancea et al., 2003), nuclei (Rey et al., 
2001; Chen et al., 2008), mitochondria (Storz et al., 2005; Cowell et al., 2009), and golgi 
(Baron and Malhotra, 2002), where they can control downstream effectors. An increase of 
both PKD1 and PKD3 was observed in the membrane fraction as a result of OX1R 
stimulation by Ox-A. This implies that PKDs might have a role in signalling events taking 
place in the membrane. One intriguing possibility is that PKDs participate in the 
regulation of Ca2+ influx, since PKD1 has been previously shown to control a number of 
ion channels present in the membrane via various mechanisms (Wang et al., 2004; Ase et 
al., 2005; McEneaney et al., 2008; Wen and Evans, 2009). So far, no comparable role for 
PKD3 in ion channel regulation has been identified. 
 In order to directly test the effect of PKDs on Ca2+ responses induced by Ox-A, 
kinase dead constructs were utilized to attenuate signalling via these kinases (Hausser et 
al., 2002; Rey et al., 2006a). Over-expression of PKD1kd or PKD3kd did not alter the 
amplitudes of Ca2+ responses to any concentration of Ox-A tested in the study (1 – 100 
nM). However, the Ca2+ oscillations induced by 1 nM Ox-A were drastically changed. 
PKD1kd significantly increased the oscillation frequency while PKD3kd caused an 
apparent disruption of the oscillatory response pattern. This highlights the 
physiologically relevant consequence of the activation of PKD1 and PKD3 by Ox-A. One 
might wonder why the effects of PKDs on Ca2+ oscillations induced by Ox-A are so 
different from each other. However, this is quite conceivable in the light of recent studies 
emphasizing that the activities of the different PKD subtypes can be differentially 
regulated and targeted by the same stimulus. Each PKD subtype has a different affinity 
for the primary activator DAG (Chen et al., 2008), furthermore, PKD1 and 2 have an 
additional C-terminal auto-phosphorylation site missing from the shorter PKD3 
(reviewed in Rykx et al., 2003) and finally, PKD3 lacks the C-terminal PDZ-domain, 
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which prevents it from binding to some of the partners of PKD1 and PKD2 (Sanchez-
Ruiloba et al., 2006; Kunkel et al., 2009). The receptors are probably embedded inside 
large signalling complexes including many components, e.g. ion channels (Rey et al., 
2006b; Woo et al., 2008) and anchoring proteins like filamin-A (Rey et al., 2005; 2006b) or 
Homer (Yuan et al., 2003) play a role in controlling Ca2+ responses induced by receptor 
stimulation. Assuming that the molecules participating in OX1R signalling are similarly 
organized around the receptor, PKD1 and PKD3 could be anchored at different locations 
in the complex and thus be able to phosphorylate different proteins; this could well be 
part of the control mechanism responsible for the Ox-A induced oscillation pattern. 
6.3 TRANSIENT RECEPTOR POTENTIAL CHANNELS ARE RESPONSIBLE 
FOR THE CALCIUM INFLUX INDUCED BY LOW CONCENTRATION OF 
OREXIN-A   
The final goal was to identify the channel responsible for the Ca2+ influx induced by low 
concentration of Ox-A. The involvement of CCE is highly unlikely based on both these 
present results and earlier reports by other research groups. In excitable IMR32 cells, the 
Ca2+ response at low concentration of Ox-A could be a consequence of activation of VOCs 
or reversal of electrogenic Na+/Ca2+ exchange. The present studies excluded the possible 
involvement of both of these Ca2+ entry mechanisms as the primary channels responsible 
for the Ca2+ influx. conotoxin, a toxin known to block N-type VOCs (for review see 
Snutch, 2005), and KB-R, a blocker of the reverse mode of  Na+/Ca2+ exchange (Iwamoto et 
al., 1996), were both without any major effect. An effect on the residual non-N-type VOCs 
seems unlikely because Ox-A still activated Ca2+ entry during depolarization in the 
presence of conotoxin. Conversely, elevated concentration of Mg2+, which strongly 
blocked the response to Ox-A, did not affect the response to elevated K+ concentration.  
A large family of mammalian TRP channels, in particular the TRPC subfamily, is 
suggested to be involved in Ca2+ entry activated by GPCRs (for review see Minke and 
Cook, 2002; Clapham, 2003; 2007, Parkash and Asotra, 2010; Rowell et al., 2010). They 
appeared to be good candidates for the molecular entities responsible for OX1R activated 
Ca2+ influx. Single cell reverse transcription-PCR in different brain loci has demonstrated 
that TRPC channels and OXRs are coexpressed in neurons (Sergeeva et al., 2003). All of 
our cell models expressed TRPC channels: mRNA for the trpc1-4 channel isoforms were 
detected in CHO-hOX1-C1 cells, transcripts of all members of the trpc subfamily were 
present in differentiated IMR32 cells and HEK293OX1R cells have been previously shown 
to express trpc1, trpc3, trpc4 and trpc6 (Garcia and Schilling, 1997; Wu et al., 2000). The 
present experiments with pharmacological channel blockers revealed that Ca2+ influx 
induced by a low concentration of Ox-A was highly sensitive to Mg2+, Dex and TEA but 
unaffected by 2-APB. Certain TRP channels are inhibited by Mg2+ (Hardie et al., 1997; 
Schaefer et al., 2000; Voets et al., 2001) and these results were strikingly similar to the 
effects of Mg2+ reported by Hardie et al. (1997) using Drosophila TRP and TRPL cation 
channels. When the TRPC3 channel was overexpressed in CHO-hOX1-C1 cells, a 
constitutive ion current was observed and this current displayed the same characteristics 
with inhibition by Mg2+, Dex and TEA as Ox-A induced membrane current.  
Some TRP channel subtypes are regulated by lipid products of phospholipase activity, 
such as DAG (Minke and Cook, 2002; Rowell et al., 2010). Johansson et al. (2008) reported 
that low concentrations of Ox-A led to the production of DAG although the generation of 
IP3 could not be detected. Of the subtypes expressed in the tested cell models, TRPC3, 
60 
 
TRPC6 and TRPC7 have been shown to be activated by DAG (Hofmann et al., 1999; 
Tesfai et al., 2001; Jung et al., 2002). The present results showing that DOG, an analog of 
DAG, stimulated Ca2+ entry in both CHO-hOX1-C1 and differentiated IMR32 cells are 
evidence that these cell lines express DAG-activated Ca2+ channels. As data indicated 
from IMR32 cells, the DOG induced [Ca2+]i elevation was similarly sensitive to Mg2+ and 
Dex as the Ca2+ response to low concentrations of Ox-A. DAG is the main activator of 
PKC and this kinase has been demonstrated to have an unexpected role in the regulation 
of TRPC channel function. TRPC3, TRPC5, TRPC6 and TRPC7 are inhibited after the 
activation of PKC (Venkatachalam et al., 2003; Trebak et al., 2003; 2005). Thus these 
present observations of the tight regulation of Ca2+ responses induced by low 
concentrations of Ox-A by PKC are in good agreement with the possible role of TRPC 
channels in Ox-A induced Ca2+ entry.  
In order to more directly test the involvement of TRPC channels in Ox-A induced Ca2+ 
responses, the cells were transfected with truncated constructs of the channels exerting 
dominant negative effects on channel function. The responses at low concentrations of 
Ox-A were significantly lower in the cells overexpressing truncated channel constructs 
than in the control cells while the responses at higher concentrations of Ox-A remained 
unaffected. In CHO-hOX1-C1 and HEK293OX1R cells, the main channel involved seemed 
to be TRPC3, but in both cell lines also trpc1N and in HEK293OX1R cells trpc4N had 
significant effects. Ca2+ oscillations observed in HEK293OX1R cells were disrupted by 
overexpression of trpc3N, pointing to a role of TRPC3 in the generation and maintenance 
of the oscillatory response pattern, especially when bearing in mind the sensitivity of the 
oscillations to Mg2+, a known blocker of TRPC3 channel. Several studies have previously 
demonstrated Ca2+ oscillations activated by DAG and/or suggested an involvement of 
DAG-activated TRPC3 (or TRPC6/7) (Grimaldi et al., 2003; Shlykov and Sanborn, 2004; 
Bird and Putney, 2005; Wedel et al., 2007). Other members of TRPC subfamily have also 
been proposed to participate in the regulation of Ca2+ oscillations (Wu X. et al., 2002; Rey 
et al., 2006b). The high sensitivity of TRPC3 to changes in [Ca2+]i (Zitt et al., 1997) makes it 
a feasible candidate for being the channel responsible for the oscillatory responses 
through feedback and feed-forward mechanisms. Although TRPC3 has not been reported 
to be activated by AA, which seems to play an important role in Ca2+ oscillations induced 
by Ox-A, there are studies pointing to the regulation of other mammalian TRPC channels 
and Drosophila TRP and TRPL channels by AA (Chyb et al., 1999; Wu X. et al., 2002; 
Harteneck et al., 2007). At first glance, the effects of trpc3N and PKD3kd on Ox-A 
induced Ca2+ oscillations seem to be very similar. However, a detailed analysis of TRPC3 
sequence revealed no consensus sites for PKD phosphorylation. The effect of PKD3kd 
also differed from that of trpc3N, since no effect was observed on the magnitude of the 
peak [Ca2+]i elevation which, on the other hand, was considerably attenuated by 
interference with TRPC3 function. Thus TRPC3 is unlikely to be the primary target of 
PKD3 phosphorylation. 
In IMR32 cells, it was not possible to observe any significant effect of trpc3N 
overexpression on Ox-A induced Ca2+ responses. This may be due to a too low expression 
level or an inability of trpc3N to interact sufficiently well with the endogenous related 
channel subunits. Therefore a full-length, triple-mutated trpc6 dominant-negative 
construct (trpc6DN) was tested, since this has been shown to inhibit ion fluxes through 
both TRPC6 and TRPC3 (Hofmann et al., 2002). There was a significant inhibition of 
elevation of [Ca2+]i induced by low concentrations of both Ox-A and DOG. As TRPC 
channels are believed to form homo- and heterotetrameric channel complexes, especially 
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with the partners from the same subfamilies, the subfamily of  DAG-activated TRPC3, 
TRPC6 and TRPC7 channels may well create the channel complexes involved in the 
OX1R-mediated Ca2+ influx in IMR32 cells. 
6.4 PHYSIOLOGICAL RELEVANCE OF THE RESULTS   
Recombinant cell models were utilized to study exclusively OX1R signalling in 
homogenous environments. Caution is necessary in extrapolating the results obtained in 
this study to neurons in their native environment, but the study has established a firm 
basis for future investigations. Similar basic signalling mechanisms, including activation 
of G-proteins and TRPC channel subunits, are functional in neuronal and non-neuronal 
cells, although in neurons, downstream pathways (e.g. different types of ion channels) 
may complicate the interpretation of data. Previous functional studies with 
recombinantly expressed orexin receptors in neuron-like cell lines (PC12 and Neuro2A) 
have revealed the same basic features as those described in CHO-K1 cells (Holmqvist et 
al., 2002). Despite explicit testing, Ca2+ release from the intracellular stores has not been 
demontrated in native neurons (van den Pol et al., 1998; Kohlmeier et al., 2004) indicating 
that Ca2+ influx from the extracellular space is the primary response to OX1R stimulation 
also in neurons. The results obtained in IMR32 cells excluded the involvement of two 
previously postulated neuronal Ca2+ entry pathways, Na+/Ca2+ exchange and VOCs 
(Kukkonen et al., 2002; Ferguson and Samson, 2003), in the OX1R mediated Ca2+ influx, 
reinforcing the conclusions drawn from the investigations in CHO-hOX1-C1 and 
HEK293OX1R cells. Usually with neurons, higher concentrations of Ox-A have been used 
and this complicates any comparison with the present results. However, the functions 
appearing at low concentrations of agonists can be hypothesized as being the primary 
responses of the receptor and thus more physiologically relevant (Kukkonen and 
Akerman, 2001). This provides extra value to the present investigations. It is also 
important to note that activation of the channel by Ox-A in CHO-hOX1-C1 cells was 
observed to depolarize the cells by about 10 mV, which implies that the same signalling 
mechanism may also be of significance in excitatory cells.  
Experiments in native systems are complicated by several aspects. Analysis of 
responses has proven difficult due to the variations obtained in the data (Kukkonen et al., 
2002; Ferguson and Samson, 2003). Furthermore, the majority of native cells appear to 
express OX1R together with OX2R, which are both activated by Ox-A (Kukkonen et al., 
2002) and which, at least in some cells, couple to different messenger systems (Ferguson 
and Samson, 2003). Thus it is difficult to dissect the signalling attributable to a single 
receptor. Orexin receptors are promiscuous and may interact with several different G-
proteins as well as other second messengers (Ferguson and Samson, 2003). The actions of 
orexins may be highly dependent on cellular microenvironments. Furthermore, the high 
concentrations of agonists required for visible responses in native neurons are indicative 
of spatially restricted areas of function. Although even a very low concentration of Ox-A 
can induce dramatic local responses in the cells, these are hard to observe in the current 
experimental setups. One must attempt to study the global changes induced by 
pharmacological (perhaps enormous) doses of agonists unless one is willing to accept a 
compromise and to simplify the environment at the expense of physiological relevance of 
the model.  
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7 Summary 
This study sheds light on the previously poorly characterized signalling mechanisms of 
OX1R. These results indicate that cellular responses induced by stimulation of OX1R by 
Ox-A include membrane depolarization, elevation of [Ca2+]i, an increase in the ion current 
across the plasma membrane and activation of ERK1/2, PKC , and PKD1/3. It was 
decided to focus on exploring the signalling pathways leading to Ca2+ responses and 
elucidating the regulatory elements involved in these pathways. Ca2+ responses elicited 
by low and high nanomolar concentrations of Ox-A acting on OX1R differed significantly 
from each other. High nanomolar concentrations of Ox-A activated the PLC -pathway 
leading to production of IP3, release of Ca2+ from the intracellular stores and CCE. In 
HEK293OX1R cells at these concentrations of Ox-A, Ca2+ oscillations were only seen in the 
absence of extracellular Ca2+ and the pharmacological profile of these responses indicated 
that the oscillations were being generated by the repetitive release and reuptake of stored 
Ca2+. At lower concentrations of Ox-A, no clues for the release from intracellular Ca2+ 
stores were detected, but stimulation of OX1R seemed to activate a Ca2+ permeable ion 
channel on the membrane, which was distinct from typical SOCs. The most probable 
molecular entity for the channel is DAG-activated TRPC3. PKC was found to be a pivotal 
regulator of the Ca2+ influx through the channel. In addition, the Ca2+ oscillations induced 
by a low concentration of Ox-A in HEK293OX1R cells were found to be dependent on the 
function of TRPC3 but independent of store discharge. Three newly identified targets of 
OX1R activation, PLA2, PKD1 and PKD3, were shown to have a functional role in OX1R 
signalling and to act as prominent modulators of the Ca2+ oscillations induced by Ox-A. 
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The orexin system consisting of two 
hypothalamic peptides, orexin-A and 
orexin-B, and two G-protein coupled 
receptors, orexin-1 and orexin-2 re-
ceptor, has multiple important physi-
ological effects and is implicated in 
many disease states. If one wishes to 
understand these effects and to de-
velop efficient therapies for orexin-
related disorders the detailed knowl-
edge of the signalling inside the cell 
is critical. This study sheds light on 
the previously poorly characterized 
cellular signalling mechanisms used 
by the orexin-1 receptor.
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